<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Home versus in‐patient treatment for deep vein thrombosis - Othieno, R - 2018 | Cochrane Library</title> <meta content="Home versus in‐patient treatment for deep vein thrombosis - Othieno, R - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003076.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Home versus in‐patient treatment for deep vein thrombosis - Othieno, R - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003076.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD003076.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Home versus in‐patient treatment for deep vein thrombosis" name="citation_title"/> <meta content="Richard Othieno" name="citation_author"/> <meta content="NHS Lothian, Directorate of Public Health and Health Policy" name="citation_author_institution"/> <meta content="richard.othieno@nhslothian.scot.nhs.uk" name="citation_author_email"/> <meta content="Emmanuel Okpo" name="citation_author"/> <meta content="NHS Grampian" name="citation_author_institution"/> <meta content="Rachel Forster" name="citation_author"/> <meta content="University of Edinburgh" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="1" name="citation_issue"/> <meta content="10.1002/14651858.CD003076.pub3" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/01/09" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003076.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003076.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003076.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Home Care Services; *Hospitalization; Cost‐Benefit Analysis; Fibrinolytic Agents [*therapeutic use]; Hemorrhage [chemically induced]; Heparin [adverse effects, *therapeutic use]; Heparin, Low‐Molecular‐Weight [adverse effects, therapeutic use]; Randomized Controlled Trials as Topic; Recurrence; Secondary Prevention; Thrombolytic Therapy [standards]; Venous Thrombosis [*drug therapy, mortality]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003076.pub3&amp;doi=10.1002/14651858.CD003076.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003076.pub3&amp;doi=10.1002/14651858.CD003076.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003076.pub3&amp;doi=10.1002/14651858.CD003076.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003076.pub3&amp;doi=10.1002/14651858.CD003076.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003076.pub3&amp;doi=10.1002/14651858.CD003076.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003076.pub3&amp;doi=10.1002/14651858.CD003076.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003076.pub3&amp;doi=10.1002/14651858.CD003076.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003076.pub3&amp;doi=10.1002/14651858.CD003076.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003076.pub3&amp;doi=10.1002/14651858.CD003076.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003076.pub3&amp;doi=10.1002/14651858.CD003076.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003076.pub3&amp;doi=10.1002/14651858.CD003076.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003076.pub3&amp;doi=10.1002/14651858.CD003076.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003076.pub3&amp;doi=10.1002/14651858.CD003076.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003076.pub3&amp;doi=10.1002/14651858.CD003076.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003076.pub3&amp;doi=10.1002/14651858.CD003076.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003076.pub3&amp;doi=10.1002/14651858.CD003076.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003076.pub3&amp;doi=10.1002/14651858.CD003076.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003076.pub3&amp;doi=10.1002/14651858.CD003076.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003076.pub3&amp;doi=10.1002/14651858.CD003076.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003076.pub3&amp;doi=10.1002/14651858.CD003076.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003076.pub3&amp;doi=10.1002/14651858.CD003076.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003076.pub3&amp;doi=10.1002/14651858.CD003076.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD003076.pub3&amp;doi=10.1002/14651858.CD003076.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="z6k50IFd";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD003076\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD003076\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003076\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003076\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","ms","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD003076.pub3",title:"Home versus in\\u2010patient treatment for deep vein thrombosis",firstPublishedDate:"Jan 9, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Vascular Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=z6k50IFd&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003076.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD003076.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD003076.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD003076.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003076.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD003076.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD003076.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD003076.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD003076.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD003076.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>9893 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD003076.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003076.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003076.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003076.pub3/full#CD003076-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003076.pub3/full#CD003076-sec-0078"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003076.pub3/full#CD003076-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003076.pub3/full#CD003076-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003076.pub3/full#CD003076-sec-0027"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003076.pub3/full#CD003076-sec-0028"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003076.pub3/full#CD003076-sec-0052"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003076.pub3/full#CD003076-sec-0072"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003076.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003076.pub3/appendices#CD003076-sec-0083"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003076.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003076.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD003076.pub3/media/CDSR/CD003076/table_n/CD003076StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD003076.pub3/media/CDSR/CD003076/table_n/CD003076StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003076.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003076.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD003076.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD003076.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD003076.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD003076.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Home versus in‐patient treatment for deep vein thrombosis</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003076.pub3/information#CD003076-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Richard Othieno</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003076.pub3/information#CD003076-cr-0003">Emmanuel Okpo</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD003076.pub3/information#CD003076-cr-0004">Rachel Forster</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/information/en#CD003076-sec-0092">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 09 January 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD003076.pub3">https://doi.org/10.1002/14651858.CD003076.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD003076-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD003076-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD003076-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD003076-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD003076-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD003076-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD003076-abs-0001" lang="en"> <section id="CD003076-sec-0001"> <h3 class="title" id="CD003076-sec-0001">Background</h3> <p>Deep vein thrombosis (DVT) occurs when a blood clot blocks blood flow through a vein, which can occur after surgery, after trauma, or when a person has been immobile for a long time. Clots can dislodge and block blood flow to the lungs (pulmonary embolism (PE)), causing death. DVT and PE are known by the term venous thromboembolism (VTE). Heparin (in the form of unfractionated heparin (UFH)) is a blood‐thinning drug used during the first three to five days of DVT treatment. Low molecular weight heparins (LMWHs) allow people with DVT to receive their initial treatment at home instead of in hospital. This is an update of a review first published in 2001 and updated in 2007. </p> </section> <section id="CD003076-sec-0002"> <h3 class="title" id="CD003076-sec-0002">Objectives</h3> <p>To compare the incidence and complications of venous thromboembolism (VTE) in patients treated at home versus patients treated with standard in‐patient hospital regimens. Secondary objectives included assessment of patient satisfaction and cost‐effectiveness of treatment. </p> </section> <section id="CD003076-sec-0003"> <h3 class="title" id="CD003076-sec-0003">Search methods</h3> <p>For this update, the Cochrane Vascular Information Specialist searched the Cochrane Vascular Specialised Register (last searched 16 March 2017), the Cochrane Central Register of Controlled Trials (CENTRAL; 2017, Issue 2), and trials registries. We also checked the reference lists of relevant publications. </p> </section> <section id="CD003076-sec-0004"> <h3 class="title" id="CD003076-sec-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs) examining home versus hospital treatment for DVT, in which DVT was clinically confirmed and was treated with LMWHs or UFH. </p> </section> <section id="CD003076-sec-0005"> <h3 class="title" id="CD003076-sec-0005">Data collection and analysis</h3> <p>One review author selected material for inclusion, and another reviewed the selection of trials. Two review authors independently extracted data and assessed included studies for risk of bias. Primary outcomes included combined VTE events (PE and recurrent DVT), gangrene, heparin complications, and death. Secondary outcomes were patient satisfaction and cost implications. We performed meta‐analysis using fixed‐effect models with risk ratios (RRs) and 95% confidence intervals (CIs) for dichotomous data. </p> </section> <section id="CD003076-sec-0006"> <h3 class="title" id="CD003076-sec-0006">Main results</h3> <p>We included in this review seven RCTs involving 1839 randomised participants with comparable treatment arms. All seven had fundamental problems including high exclusion rates, partial hospital treatment of many in the home treatment arms, and comparison of UFH in hospital versus LMWH at home. These trials showed that patients treated at home with LMWH were less likely to have recurrence of VTE events than those given hospital treatment with UFH or LMWH (fixed‐effect risk ratio (RR) 0.58, 95% confidence interval (CI) 0.39 to 0.86; 6 studies; 1708 participants; P = 0.007; low‐quality evidence). No clear difference was seen between groups for major bleeding (RR 0.67, 95% CI 0.33 to 1.36; 6 studies; 1708 participants; P = 0.27; low‐quality evidence), minor bleeding (RR 1.29, 95% CI 0.94 to 1.78; 6 studies; 1708 participants; P = 0.11; low‐quality evidence), or mortality (RR 0.69, 95% CI 0.44 to 1.09; 6 studies; 1708 participants; P = 0.11; low‐quality evidence). The included studies reported no cases of venous gangrene. We could not combine patient satisfaction and quality of life outcomes in meta‐analysis owing to heterogeneity of reporting, but two of three studies found evidence that home treatment led to greater improvement in quality of life compared with in‐patient treatment at some point during follow‐up, and the third study reported that a large number of participants chose to switch from in‐patient care to home‐based care for social and personal reasons, suggesting it is the patient's preferred option (very low‐quality evidence). None of the studies included in this review carried out a full cost‐effectiveness analysis. However, a small randomised economic evaluation of the two alternative treatment settings involving 131 participants found that direct costs were higher for those in the in‐patient group. These findings were supported by three other studies that reported on their costs (very low‐quality evidence). </p> <p>Quality of evidence for data from meta‐analyses was low to very low. This was due to risk of bias, as many of the included studies used unclear randomisation techniques, and blinding was a concern for many. Also, indirectness was a concern, as most studies included a large number of participants randomised to the home (LMWH) treatment group who were treated in hospital for some or all of the treatment period. A further issue for some outcomes was heterogeneity that was evident in measurement and reporting of outcomes. </p> </section> <section id="CD003076-sec-0007"> <h3 class="title" id="CD003076-sec-0007">Authors' conclusions</h3> <p>Low‐quality evidence suggests that patients treated at home with LMWH are less likely to have recurrence of VTE than those treated in hospital. However, data show no clear differences in major or minor bleeding, nor in mortality (low‐quality evidence), indicating that home treatment is no worse than in‐patient treatment for these outcomes. Because most healthcare systems are moving towards more LMWH usage in the home setting it is unlikely that additional large trials will be undertaken to compare these treatments. Therefore, home treatment is likely to become the norm, and further research will be directed towards resolving practical issues by devising local guidelines that include clinical prediction rules, developing biomarkers and imaging that can be used to tailor therapy to disease severity, and providing training for community healthcare workers who administer treatment and monitor treatment progress. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD003076-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD003076-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD003076-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD003076-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD003076-abs-0007">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD003076-abs-0006">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD003076-abs-0005">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD003076-abs-0004" lang="en"> <h3>Home versus in‐patient treatment for deep vein blood clots</h3> <p><b>Background</b> </p> <p>Deep vein thrombosis (DVT) occurs when a blood clot blocks the flow of blood through a vein, generally in the legs. This can happen after surgery, after trauma, when a person is immobile for a long time, or for no obvious reason. Clots can dislodge and block blood flow to the lungs (pulmonary embolism (PE)), which can be fatal. DVT and PE are known as venous thromboembolism (VTE). Heparin is a blood‐thinning drug that is used to treat DVT during the first three to five days. Unfractionated heparin (UFH) is administered intravenously in hospital with laboratory monitoring. Low molecular weight heparins (LMWHs) are given by subcutaneous injection once a day and can be given at home. Oral anticoagulants are then continued for three to six months. After recovery from the acute episode, people may develop post‐thrombotic syndrome with leg swelling, varicose veins, and ulceration. </p> <p><b>Study characteristics and key results</b> </p> <p>Seven randomised controlled trials involving 1839 patients with clinically confirmed DVT compared home (LMWH) versus hospital (unfractionated heparin, or LMWH in one trial) treatment. Trials had limitations, including high exclusion rates and designs that did not take into account short hospital stays for any of the people treated at home to allow fair comparison of heparin in hospital with LMWH at home. </p> <p>Trials showed that patients treated at home with LMWH had less recurrence of VTE than hospital‐treated patients. The review showed no clear differences between treatment groups for major bleeding, minor bleeding, or death. No study reported venous gangrene. We could not pool information on patient satisfaction and quality of life, as studies had different ways of reporting these, but two of the three studies reporting on quality of life provided evidence that home treatment led to greater improvement in quality of life compared with in‐patient treatment, at some point during follow‐up. The third study reported that a large number of participants chose to switch from in‐patient care to home‐based care for social and personal reasons, indicating that home treatment was better accepted than in‐patient treatment. Studies that looked at cost found that cost of home management was lower per incident of treatment. </p> <p><b>Quality of the evidence</b> </p> <p>Overall, the quality of evidence of the available data was low to very low owing to risk of bias, indirectness, and differences in measuring and reporting of outcomes. Risk of bias is a concern, as many of the included studies did not fully explain how they randomised and allocated participants to treatments, and blinding techniques described were not clear. Full blinding would be difficult if not impossible for these types of treatments (home vs hospital), but some techniques could be put in place such as using the same treatment medications or blinding those who measure outcomes. Another concern of reviewers was that in some studies, participants randomised to home treatment actually ended up being treated in hospital but remained in their assigned treatment for the analysis (this is known as indirectness). This makes it hard to determine whether trial results actually can be used to answer the question of whether home versus hospital treatment for DVT is superior. A further concern regarding a few of outcomes is variation in the way outcomes were measured and reported. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD003076-sec-0078" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD003076-sec-0078"></div> <h3 class="title" id="CD003076-sec-0079">Implications for practice</h3> <section id="CD003076-sec-0079"> <p>This review presents low‐quality evidence suggesting that patients treated at home with low molecular weight heparin (LMWH) are less likely to have recurrence of venous thromboembolism (VTE) than those treated in hospital. Researchers have found no clear differences in major or minor bleeding complications, nor in mortality (low‐quality evidence), indicating that treatment at home with LMWH is not more harmful than treatment in an in‐patient setting with LMWH or unfractionated heparin (UFH). Despite the limitations of reviewed trials, low‐quality evidence suggests that home treatment of patients with DVT is more effective than standard hospital treatment. </p> </section> <h3 class="title" id="CD003076-sec-0080">Implications for research</h3> <section id="CD003076-sec-0080"> <p>It is unlikely that definitive evidence on the safety of home treatment will be forthcoming for reasons addressed in the discussion. This is underscored by the fact that during our search, we identified no other high‐quality randomised controlled trials published after 2005. Also, treatment of individuals with thromboembolism with LMWH is being incorporated into local health authority guidelines that include at‐home administration practices (<a href="./references#CD003076-bbs2-0038" title="East Lancashire Medicines ManagementBoard . Use of Low Molecular Weight Heparins (LMWH) (e.g. Tinzaparin) in Primary Care: Best Practice Guideline. www.elmmb.nhs.uk/policies‐and‐guidelines/guidelines/ (accessed 20 June 2017); Vol. Version 3. ">East Lancashire Health Economy 2015</a>; <a href="./references#CD003076-bbs2-0056" title="WongM , ButtIL , on behalf of Wirral Drug and Therapeutics Committee. Low Molecular Weight Heparin Prescribing and Administration (Adults). http://mm.wirral.nhs.uk/document_uploads/guidelines/LMWHprescribingandadministrationv1a.pdf.. Version: v1a 2014 (accessed 13 July 2017). ">Wong 2014</a>). A larger database of accumulated uncontrolled studies that can be compared only with historical controls is needed. Anecdotal notes may describe treatment failure but as these occurrences will be rare, it is possible that they will not be published. </p> <p>It has been suggested by <a href="./references#CD003076-bbs2-0037" title="BaronRM , GoldhaberSZ . Deep venous thrombosis: early discharge strategies and outpatient management. Journal of Thrombosis and Thrombolysis1999;7(2):113‐22. ">Baron 1999</a> that patients should be allocated on a triage basis: (1) standard in‐patient regimen for those with intercurrent illness or massive VTE; (2) partial home treatment for those receiving the diagnosis in hospital but fit enough for discharge; and (3) complete home treatment. The ideal trial would compare LMWH only in each arm, would exclude 25% or fewer participants from entry into the trial, and would present trial results in three groups. These issues should be given further examination. </p> <p>Some practical issues remain to be resolved.</p> <p> <ul id="CD003076-list-0008"> <li> <p>Should the patient be admitted at all if suitable for home treatment?</p> </li> <li> <p>Should LMWH be given on suspicion or only on confirmation of the diagnosis?</p> </li> <li> <p>How would the treatment comparison be changed by use of newer direct oral anticoagulants versus more traditional LMWH? </p> </li> <li> <p>Should exclusion criteria be relaxed to favour greater entry to home treatment? For example, should a healthy pregnancy preclude home treatment? </p> </li> <li> <p>Should a screening test such as D‐dimer levels be used?</p> </li> <li> <p>Should the system be controlled by the traditional physician's team, or should specialist anticoagulant nurses be trained? If so, will a lead clinician continue to accept overall responsibility? </p> </li> <li> <p>How should local guidelines be developed that include clinical prediction rules, biomarkers, and imaging that can be used to tailor therapy to disease severity? </p> </li> <li> <p>How should community healthcare workers be trained to administer treatment and monitor treatment progress? </p> </li> </ul> </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD003076-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD003076-sec-0022"></div> <div class="table" id="CD003076-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Treatment of DVT at home compared with treatment in hospital</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>How does treatment of DVT at home compare with treatment in hospital?</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with diagnosed DVT<br/> <b>Setting:</b> hospital and home<br/> <b>Intervention:</b> treatment of DVT at home with LMWH<sup>a</sup><br/> <b>Comparison:</b> treatment of DVT in hospital with UFH or LMWH<sup>b</sup> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)<br/> Follow‐up</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with treatment of DVT in hospital</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with treatment of DVT at home</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Recurrence of VTE</b><br/> Follow‐up: range 3 months to 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>1708<br/> (6 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>c,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.58<br/> (0.39 to 0.86) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31 fewer per 1000<br/> (45 fewer to 10 fewer) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Venous gangrene</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This outcome was not reported by any of the included studies.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Major bleeding</b><br/> Follow‐up: range 14 days to 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>1708<br/> (6 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>c,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.67<br/> (0.33 to 1.36) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 fewer per 1000<br/> (14 fewer to 8 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Minor bleeding</b><br/> Follow‐up: range 14 days to 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>1708<br/> (6 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>c,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.29<br/> (0.94 to 1.78) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21 more per 1000<br/> (4 fewer to 56 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Death</b><br/> fFollow‐up: range 3 months to 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>1708<br/> (6 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>c,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.69<br/> (0.44 to 1.09) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 fewer per 1000<br/> (28 fewer to 4 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Patient satisfaction/Quality of life</b><br/> Follow‐up: range 7 days to 6 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1031<br/> (3 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>c,d,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>See comment.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Two studies reported greater improvement in QoL among participants treated at home than among those receiving in‐patient treatment; the third study reported that a large number of participants chose to switch from in‐patient care to home‐based care, suggesting this may be patients' preferred option. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cost‐effectiveness</b><sup>f</sup><br/> Follow‐up: range 10 days to 6 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>834<br/> (4 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>c,d,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>See comment.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>One study carried out a randomised economic evaluation and reported that total direct costs were higher for participants in the in‐patient strategy group (i.e. Swedish Crown (SEK) 16,400 per participant (Euro (EUR) 1899) compared with SEK 12,100 per participant (EUR 1405)) than for those in the out‐patient (home) strategy group (P &lt; 0.0010). This was supported by 3 other studies that reported on costs. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*We calculated the assumed risk of the hospital treatment group from the average risk in the hospital treatment group (i.e. the number of participants with events divided by the total number of participants in the hospital treatment group included in the meta‐analysis). <b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> CI: confidence interval; DVT: deep vein thrombosis; LMWH: low molecular weight heparin; RR: risk ratio; UFH: unfractionated heparin; VTE: venous thromboembolism. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence.</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Home treatment refers to treatment for DVT with an LMWH that occurs outside of a hospital or in‐patient setting and can include the medication being administered by the participant or by a caregiver.<br/> <sup>b</sup>Hospital treatment refers to treatment for DVT with an LMWH or a UFH in a hospital or in‐patient setting that is administered by care staff.<br/> <sup>c</sup>Downgraded one level owing to risk of bias from unclear randomisation techniques and blinding measures in most included studies.<br/> <sup>d</sup>Downgraded one level owing to indirectness because most of the included studies had few participants actually treated at home with an LMWH, and many were treated in hospital.<br/> <sup>e</sup>Downgraded one level owing to heterogeneity because the included studies used different methods and time points for gathering information on this outcome.<br/> <sup>f</sup>We are reporting on the cost‐effectiveness analysis reported in the included studies. We have not carried out an economic analysis ourselves. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD003076-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD003076-sec-0023"></div> <section id="CD003076-sec-0024"> <h3 class="title" id="CD003076-sec-0024">Description of the condition</h3> <p>Deep vein thrombosis (DVT) is a frequent disorder in western medical practice, affecting one to two per thousand of the adult population annually. DVT occurs in conjunction with malignancy, after surgery, and after trauma and immobilisation, and can occur spontaneously. It manifests in the acute stage with leg symptoms and, in a small minority, with potentially fatal pulmonary embolism (PE). Venous thromboembolism (VTE) is a term that refers to both DVT and PE. After recovery from the acute episode, people may develop post‐thrombotic syndrome with leg swelling, varicosis, and ulceration. Gold standard techniques for diagnosing DVT include ascending venography and duplex ultrasound scanning. Deep vein thrombosis is most commonly managed by anticoagulants to prevent spread of the clot proximally and to allow it to become adherent or undergo fibrinolysis, thus reducing the risk of PE. Currently used anticoagulant treatments include unfractionated and low molecular weight heparin (UFH and LMWH, respectively), as well as vitamin K antagonists (VKAs), primarily warfarin, and direct oral anticoagulants (DOACs) (<a href="./references#CD003076-bbs2-0048" title="National Institute for Health and Care Excellence (NICE). Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (CG144). www.nice.org.uk/guidance/CG144 (accessed 20 June 2017). ">NICE 2012</a>; <a href="./references#CD003076-bbs2-0051" title="RobertsonL , KestevenP , McCaslinJE . Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of deep vein thrombosis. Cochrane Database of Systematic Reviews2015, Issue 6. [DOI: 10.1002/14651858.CD010956.pub2] ">Robertson 2015</a>; <a href="./references#CD003076-bbs2-0055" title="vanEsN , CoppensM , SchulmanS , MiddeldorpS , BüllerHR . Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. Blood2014;124:1968‐75. ">van Es 2014</a>). </p> </section> <section id="CD003076-sec-0025"> <h3 class="title" id="CD003076-sec-0025">Description of the intervention</h3> <p>In the hospitalised patient, UFH is usually administered intravenously, with laboratory monitoring for about five days, overlapping with oral anticoagulants, which are continued for three to six months. LMWH is administered daily by subcutaneous injection; it can be delivered at home without the need for continuous laboratory monitoring and may be followed by an oral anticoagulant regimen. </p> </section> <section id="CD003076-sec-0026"> <h3 class="title" id="CD003076-sec-0026">Why it is important to do this review</h3> <p>Development of LMWHs has resulted in many trials investigating their efficaciousness and safety, as compared with UFH. These studies show that LMWH is at least as effective as UFH; some meta‐analyses and reviews show that LMWH is more effective and safer than UFH (<a href="./references#CD003076-bbs2-0039" title="ErkensPMG , PrinsMH . Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database of Systematic Reviews2010, Issue 9. [DOI: 10.1002/14651858.CD001100.pub3] ">Erkens 2010</a>; <a href="./references#CD003076-bbs2-0046" title="LeizoroviczA , SimmoneauG , DecoususH , BoisselJP . Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep vein thrombosis: a meta‐analysis. BMJ1994;309:299‐304. ">Leizorovicz 1994</a>; <a href="./references#CD003076-bbs2-0047" title="LensingAW , PrinsMH , DavidsonBL , HirshJ . Treatment of deep venous thrombosis with low‐molecular‐weight heparins. A meta‐analysis. Archives of Internal Medicine1995;155(6):601‐7. ">Lensing 1995</a>). Because LMWH is given subcutaneously once per day and requires no laboratory monitoring, it is possible to treat people with LMWH at home. Although LMWH has been available since 1976, home treatment has not been investigated further since the time it was first reported in 1988 (<a href="./references#CD003076-bbs2-0036" title="BakkerM , DekkerPJ , KnotEA , vanBergenPF , JonkerJJ . Home treatment for deep venous thrombosis with low molecular weight heparin [letter]. Lancet1988;2:1142. ">Bakker 1988</a>). Rigorous evaluation of home versus in‐patient care is required to inform policy on alternative strategies for treating patients with DVT. Home treatment of DVT offers potential cost savings and improved social acceptability for the patients. This review aims to update the review that was first published in 2001 and updated in 2007 (<a href="./references#CD003076-bbs2-0058" title="OthienoR , Abu AffanM , OkpoE . Home versus in‐patient treatment for deep vein thrombosis. Cochrane Database of Systematic Reviews2007, Issue 3. [DOI: 10.1002/14651858.CD003076.pub2] ">Othieno 2007</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD003076-sec-0027" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD003076-sec-0027"></div> <p>To compare the incidence and complications of venous thromboembolism (VTE) in patients treated at home versus patients treated with standard in‐patient hospital regimens. Secondary objectives included assessment of patient satisfaction and cost‐effectiveness of treatment. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD003076-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD003076-sec-0028"></div> <section id="CD003076-sec-0029"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD003076-sec-0030"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled trials (RCTs) in which participants were randomised to home or in‐patient treatment. Exclusion criteria before randomisation had to be stated and the trial author's policy regarding protocol violations and withdrawals known (i.e. intention‐to‐treat basis). </p> </section> <section id="CD003076-sec-0031"> <h4 class="title">Types of participants</h4> <p>We included people with proven VTE who had no contraindication to heparin therapy, and whose home circumstances were adequate. Participants had to present with objective evidence of DVT such as duplex scanning and/or venography. </p> </section> <section id="CD003076-sec-0032"> <h4 class="title">Types of interventions</h4> <p>We included studies that compared home versus hospital management with LMWH (which can be used in either setting) or UFH (which is used in hospital only). Trials involving a placebo group are not ethically acceptable. </p> </section> <section id="CD003076-sec-0033"> <h4 class="title">Types of outcome measures</h4> <section id="CD003076-sec-0034"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD003076-list-0001"> <li> <p>Recurrence of VTE: PE or recurrence of DVT (depending on length of follow‐up)</p> </li> <li> <p>Venous gangrene</p> </li> <li> <p>Heparin complications: major and minor bleeding (the former defined as bleeding within the abdomen, cranium, or eye, or requiring transfusion, or causing a fall in haemoglobin ≥ 2 g/dL) </p> </li> <li> <p>Death</p> </li> </ul> </p> <p>Ideally, evidence of PE is derived from lung scans, spiral computed tomography (CT), or pulmonary angiography, but as these methods were not likely to be widely available, we considered X‐rays, electrocardiograms (ECGs), and strong clinical signs acceptable. In the event of death, postmortem evidence was desirable. </p> </section> <section id="CD003076-sec-0035"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD003076-list-0002"> <li> <p>Patient satisfaction and quality of life</p> </li> <li> <p>Cost‐effectiveness of treatment (as reported by individual studies)</p> </li> </ul> </p> <p>We will also report on other outcomes of interest (i.e. post‐thrombotic syndrome or length of stay in hospital), when reported by individual studies. </p> </section> </section> </section> <section id="CD003076-sec-0036"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD003076-sec-0037"> <h4 class="title">Electronic searches</h4> <p>For this update, the Cochrane Vascular Information Specialist (CIS) searched the following databases for relevant trials. </p> <p> <ul id="CD003076-list-0003"> <li> <p>Cochrane Vascular Specialised Register (16 March 2017).</p> </li> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2017, Issue 2) via the Cochrane Register of Studies Online. </p> </li> </ul> </p> <p>See <a href="./appendices#CD003076-sec-0084">Appendix 1</a> for details of the search strategy used for CENTRAL. </p> <p>The Cochrane Vascular Specialised Register is maintained by the CIS and is constructed from weekly electronic searches of MEDLINE Ovid, Embase Ovid, the Cumulative Index to Nursing and Allied Health Literature (CINAHL), and the Allied and Complementary Medicine Database (AMED), as well as through handsearching of relevant journals. The full list of databases, journals, and conference proceedings searched, as well as the search strategies used, are described in the <a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PVD/frame.html" target="_blank">Specialised Register</a> section of the Cochrane Vascular module in the Cochrane Library (<a href="http://www.cochranelibrary.com/" target="_blank">www.cochranelibrary.com</a>). </p> <p>In addition, the CIS searched the following trial databases for details of ongoing and unpublished studies (16 March 2017). See <a href="./appendices#CD003076-sec-0085">Appendix 2</a>. </p> <p> <ul id="CD003076-list-0004"> <li> <p>World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) Search Portal (<a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch</a>). </p> </li> <li> <p>ClinicalTrials.gov (<a href="http://clinicaltrials.gov/" target="_blank">clinicaltrials.gov</a>). </p> </li> <li> <p>International Standard Randomised Controlled Trial Number (ISRCTN) Registry (<a href="http://www.isrctn.com/" target="_blank">www.isrctn.com</a>). </p> </li> </ul> </p> </section> <section id="CD003076-sec-0038"> <h4 class="title">Searching other resources</h4> <p>We identified additional articles by reviewing the references of relevant papers identified by the initial search. </p> </section> </section> <section id="CD003076-sec-0039"> <h3 class="title" id="CD003076-sec-0039">Data collection and analysis</h3> <section id="CD003076-sec-0040"> <h4 class="title">Selection of studies</h4> <p>For this update, three review authors (RO, EO, RF) independently selected trials. Final selection of articles was agreed upon through discussion and consensus. </p> </section> <section id="CD003076-sec-0041"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (RO, EO) independently extracted data from existing and newly included trials using the criteria designated by Cochrane Vascular. For some references, we sought clarification from trial authors. Two review authors (RO, EO) performed data entry. </p> </section> <section id="CD003076-sec-0042"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (RO, EO) independently assessed the risk of bias of all included studies using Cochrane's 'Risk of bias' tool, as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD003076-bbs2-0043" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org. ">Higgins 2011</a>). We rated studies as having 'low risk of bias' (plausible bias that is unlikely to seriously alter the results); 'high risk of bias' (plausible bias that seriously weakens confidence in the results); or 'unclear risk of bias' (plausible bias that raises some doubt about results). We assessed included RCTs against the six domains listed below. </p> <p> <ul id="CD003076-list-0005"> <li> <p>Sequence generation: Was the allocation sequence adequately described?</p> </li> <li> <p>Allocation concealment: Was allocation adequately concealed?</p> </li> <li> <p>Blinding of participants, personnel, and outcome assessors: Was knowledge of the allocation intervention adequately prevented during the study? </p> </li> <li> <p>Incomplete outcome data: Were incomplete outcome data adequately addressed?</p> </li> <li> <p>Selective outcome reporting: Are reports of the study free of the suggestion of selective outcome reporting? </p> </li> <li> <p>Other sources of bias: Did the study appear to be free of other problems that could put it at high risk of bias? </p> </li> </ul> </p> </section> <section id="CD003076-sec-0043"> <h4 class="title">Measures of treatment effect</h4> <p>Two review authors (RO, EO) performed the data analysis according to the statistical guidelines provided for review authors by Cochrane Vascular. When data were sufficient, we calculated risk ratios (RRs) with 95% confidence intervals (CIs) using Review Manager software (<a href="./references#CD003076-bbs2-0050" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). </p> </section> <section id="CD003076-sec-0044"> <h4 class="title">Unit of analysis issues</h4> <p>None of the included studies applied non‐standard designs, such as cross‐over trials or cluster‐randomised trials. Therefore we made no adjustments for measurement effects. The individual participant was the unit of analysis. </p> </section> <section id="CD003076-sec-0045"> <h4 class="title">Dealing with missing data</h4> <p>We aimed to conduct a complete‐case analysis in this Cochrane Review, such that we included in the analysis all participants with a recorded outcome. We analysed data on an intention‐to‐treat basis as far as possible. When data were missing, we made attempts to obtain them from the original investigators. When they were unobtainable, we analysed only available data, based on the numerator and the denominator reported in study results or calculable from reported percentages. </p> </section> <section id="CD003076-sec-0046"> <h4 class="title">Assessment of heterogeneity</h4> <p>We examined heterogeneity between trials by visually examining forest plots to judge whether any differences between studies in direction or size of the treatment effect were apparent. We also considered I² and Tau² statistics and the P value of the Chi² test for heterogeneity. If we identified heterogeneity among trials (i.e. if the value of I² was greater than 30%, and the value of Tau² was greater than zero or the P value of the Chi² test for heterogeneity was lower than 0.1), we planned to explore heterogeneity by performing prespecified sensitivity analysis as described below. </p> </section> <section id="CD003076-sec-0047"> <h4 class="title">Assessment of reporting biases</h4> <p>In view of the difficulty involved in detecting and correcting for publication bias and other reporting biases, we aimed to minimise their potential impact by ensuring a comprehensive search for eligible studies and by staying alert for duplication of data. We planned to use a funnel plot to assess the possibility of small‐study effects (a tendency for estimates of the intervention effect to be more beneficial in smaller studies) for the primary review outcomes when we included 10 or more studies in meta‐analyses (<a href="./references#CD003076-bbs2-0043" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org. ">Higgins 2011</a>). We intended to cautiously consider visible asymmetry in the funnel plot as a possible indication of publication bias. </p> </section> <section id="CD003076-sec-0048"> <h4 class="title">Data synthesis</h4> <p>We carried out statistical analysis using Review Manager software (<a href="./references#CD003076-bbs2-0050" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We used a fixed‐effect meta‐analysis for combining data when it was reasonable to assume that studies were estimating the same underlying treatment effect (i.e. when trials were examining the same intervention, and when we judged that trial populations and methods were sufficiently similar). </p> <p>We planned to use random‐effects meta‐analysis if clinical heterogeneity was sufficient to expect that underlying treatment effects differed between trials, or if we detected substantial statistical heterogeneity. </p> </section> <section id="CD003076-sec-0049"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>If identified, we planned to explore any possible evidence of heterogeneity within meta‐analyses by performing subgroup analysis. We planned to perform no other subgroup analyses. </p> </section> <section id="CD003076-sec-0050"> <h4 class="title">Sensitivity analysis</h4> <p>We performed sensitivity analyses by excluding studies that we judged to be at high risk of bias to determine effects on overall findings. We also performed sensitivity analysis if a single study carried most of the weight when we included three or more studies in an analysis. We performed additional sensitivity analysis to determine the robustness of findings that included data from <a href="./references#CD003076-bbs2-0005" title="KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of patients with venous thrombosis with intravenous unfractionated heparin in hospital compared with subcutaneous low‐molecular‐weight heparin out of hospital. Annals of Hematology1996;72:A3. KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of venous thrombosis with intravenous unfractionated heparin in hospital as compared with subcutaneous low molecular weight heparin at home. New England Journal of Medicine1996;334(11):682‐7. van denBeltAGM , BossuytPMM , PrinsMH , GallusAS , BullerHR . Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis ‐ an economic evaluation. Thrombosis and Haemostasis1998;79:259‐62. ">Koopman 1996</a>, <a href="./references#CD003076-bbs2-0006" title="LevineM , GentM , HirschJ , LeclercJ , AndersonD , WeitzJ , et al. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis. New England Journal of Medicine1996;334:677‐82. O'BrienB , LevineM , WillanA , GoereeR , HaleyS , BlackhouseG , et al. Economic evaluation of outpatient treatment with low‐molecular‐weight‐heparin for proximal vein thrombosis. Archives of Internal Medicine1999;159:2298‐304. ">Levine 1996</a>, and <a href="./references#CD003076-bbs2-0007" title="RamacciottiE , AraujoGR , LastoriaS , DietrichF , MaffeiFH , MussiNS . The efficacy and safety of enoxaparin once‐daily given partly at home, compared with unfractionated heparin given in the hospital in the treatment of proximal deep‐vein thrombosis, a Brazilian multicenter study. Blood2001;98(11):Abstract 4026. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , DietrichF . An open‐label, comparative study of the efficacy and safety of an outpatient single daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Blood2002;11:503a‐Abstract 1960. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , Dietrich‐NetoF , CLETRAT Investigators. Efficacy and safety of once‐daily enoxaparin given in the outpatient setting compared with in‐hospital unfractionated heparin for treatment of proximal lower limb deep‐vein thrombosis. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1401. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , KaraoglanDM , MichaelisW , et al. An open‐label, comparative study of the efficacy and safety of once‐daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Thrombosis Research2004;114(3):149‐53. ">Ramacciotti 2004</a>, when we found that participants randomised to LMWH were treated only at home, as determined by a clinician, but were not specifically assigned to home treatment. </p> <section id="CD003076-sec-0051"> <h5 class="title">'Summary of findings'</h5> <p>We presented the main findings of the review concerning quality of evidence, magnitude of effect of interventions examined, and the sum of available data for all outcomes of this review (<a href="#CD003076-sec-0033">Types of outcome measures</a>) in a 'Summary of findings' table, according to GRADE principles, as described by <a href="./references#CD003076-bbs2-0043" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org. ">Higgins 2011</a> and <a href="./references#CD003076-bbs2-0035" title="AtkinsD , BestD , BrissPA , EcclesM , Falck‐YtterY , FlottorpS , et al. GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ2004;328(7454):1490‐4. ">Atkins 2004</a>. We evaluated evidence on the basis of risk of bias of the included studies, inconsistency, indirectness, and imprecision of data, as well as publication bias. We used GRADEprofiler (GRADEpro) software to assist in preparation of the 'Summary of findings' table (<a href="./references#CD003076-bbs2-0041" title="McMaster University (developed by Evidence Prime). GRADEpro GDT. Version accessed 11 July 2017. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. ">GRADEProGDT 2015</a>), and we used the <a href="./references#CD003076-bbs2-0053" title="RyanR , HillS . How to GRADE the quality of the evidence. Cochrane Consumers and Communication Group, June 2016. Version 1.0. http://cccrg.cochrane.org/author‐resources (accessed 13 August 2017).. ">Ryan 2016</a> publication to prepare GRADE ratings. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD003076-sec-0052" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD003076-sec-0052"></div> <section id="CD003076-sec-0053"> <h3 class="title">Description of studies</h3> <section id="CD003076-sec-0054"> <h4 class="title">Results of the search</h4> <p>See <a href="#CD003076-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD003076-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD003076-fig-0001" src="/cdsr/doi/10.1002/14651858.CD003076.pub3/media/CDSR/CD003076/image_n/nCD003076-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD003076-sec-0055"> <h4 class="title">Included studies</h4> <p>In total, seven studies with a total of 1839 participants were eligible for inclusion in this review (<a href="./references#CD003076-bbs2-0001" title="BäckmanK , CarlssonP , KentsonM , HansenS , EngquistL , HallertC . Deep venous thrombosis: a new task for primary health care. Scandinavian Journal of Primary Health Care2004;22(1):44‐9. ">Bäckman 2004</a>; <a href="./references#CD003076-bbs2-0002" title="BoccalonH , EliasA , ChaleJJ , CadeneA , DumoulinA . Treatment of deep vein thrombosis at home: from theory to medical practice [French]. Bulletin de l'Academie Nationale de Medecine1998;182(1):101‐15. BoccalonH , EliasA , ChaleJJ , CadeneA , GabrielS . Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low‐molecular‐weight heparin: the Vascular Midi‐Pyrenees study. Archives of Internal Medicine2000;160(12):1769‐73. ">Boccalon 2000</a>; <a href="./references#CD003076-bbs2-0003" title="ChongBH . A randomized, prospective, multicentre study comparing the efficacy, safety and cost of once‐daily enoxaparin given at home with unfractionated heparin given in hospital in the treatment of deep‐vein thrombosis. Blood2002;100(11):Abstract 2772. ChongBH , BrightonTA , BakerRI , ThurlowP , LeeCH , ASTH DS Group. Once‐daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep‐vein thrombosis. Journal of Thrombosis and Thrombolysis2005;19(3):173‐81. ">Chong 2005</a>; <a href="./references#CD003076-bbs2-0004" title="DaskalopoulosME , DaskalopoulouSS , TzortzisE , SfiridisP , NikolaouA , DimitroulisD , et al. Long‐term treatment of deep venous thrombosis with a low molecular weight heparin (tinzaparin): a prospective randomized trial. European Journal of Vascular and Endovascular Surgery2005;29(6):638‐50. ">Daskalopoulos 2005</a>; <a href="./references#CD003076-bbs2-0005" title="KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of patients with venous thrombosis with intravenous unfractionated heparin in hospital compared with subcutaneous low‐molecular‐weight heparin out of hospital. Annals of Hematology1996;72:A3. KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of venous thrombosis with intravenous unfractionated heparin in hospital as compared with subcutaneous low molecular weight heparin at home. New England Journal of Medicine1996;334(11):682‐7. van denBeltAGM , BossuytPMM , PrinsMH , GallusAS , BullerHR . Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis ‐ an economic evaluation. Thrombosis and Haemostasis1998;79:259‐62. ">Koopman 1996</a>; <a href="./references#CD003076-bbs2-0006" title="LevineM , GentM , HirschJ , LeclercJ , AndersonD , WeitzJ , et al. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis. New England Journal of Medicine1996;334:677‐82. O'BrienB , LevineM , WillanA , GoereeR , HaleyS , BlackhouseG , et al. Economic evaluation of outpatient treatment with low‐molecular‐weight‐heparin for proximal vein thrombosis. Archives of Internal Medicine1999;159:2298‐304. ">Levine 1996</a>; <a href="./references#CD003076-bbs2-0007" title="RamacciottiE , AraujoGR , LastoriaS , DietrichF , MaffeiFH , MussiNS . The efficacy and safety of enoxaparin once‐daily given partly at home, compared with unfractionated heparin given in the hospital in the treatment of proximal deep‐vein thrombosis, a Brazilian multicenter study. Blood2001;98(11):Abstract 4026. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , DietrichF . An open‐label, comparative study of the efficacy and safety of an outpatient single daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Blood2002;11:503a‐Abstract 1960. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , Dietrich‐NetoF , CLETRAT Investigators. Efficacy and safety of once‐daily enoxaparin given in the outpatient setting compared with in‐hospital unfractionated heparin for treatment of proximal lower limb deep‐vein thrombosis. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1401. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , KaraoglanDM , MichaelisW , et al. An open‐label, comparative study of the efficacy and safety of once‐daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Thrombosis Research2004;114(3):149‐53. ">Ramacciotti 2004</a>). We identified one new study for inclusion in this review update (<a href="./references#CD003076-bbs2-0001" title="BäckmanK , CarlssonP , KentsonM , HansenS , EngquistL , HallertC . Deep venous thrombosis: a new task for primary health care. Scandinavian Journal of Primary Health Care2004;22(1):44‐9. ">Bäckman 2004</a>). This study had previously been excluded on the grounds that it did not assess any of the primary outcomes, but after further assessment, we decided we should include it, as the study did report on economic data. </p> <p>Three large trials randomised 298 (150 home and 148 hospital), 400 (202 home and 198 hospital), and 500 participants (247 home and 253 hospital), respectively (<a href="./references#CD003076-bbs2-0003" title="ChongBH . A randomized, prospective, multicentre study comparing the efficacy, safety and cost of once‐daily enoxaparin given at home with unfractionated heparin given in hospital in the treatment of deep‐vein thrombosis. Blood2002;100(11):Abstract 2772. ChongBH , BrightonTA , BakerRI , ThurlowP , LeeCH , ASTH DS Group. Once‐daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep‐vein thrombosis. Journal of Thrombosis and Thrombolysis2005;19(3):173‐81. ">Chong 2005</a>; <a href="./references#CD003076-bbs2-0005" title="KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of patients with venous thrombosis with intravenous unfractionated heparin in hospital compared with subcutaneous low‐molecular‐weight heparin out of hospital. Annals of Hematology1996;72:A3. KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of venous thrombosis with intravenous unfractionated heparin in hospital as compared with subcutaneous low molecular weight heparin at home. New England Journal of Medicine1996;334(11):682‐7. van denBeltAGM , BossuytPMM , PrinsMH , GallusAS , BullerHR . Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis ‐ an economic evaluation. Thrombosis and Haemostasis1998;79:259‐62. ">Koopman 1996</a>; <a href="./references#CD003076-bbs2-0006" title="LevineM , GentM , HirschJ , LeclercJ , AndersonD , WeitzJ , et al. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis. New England Journal of Medicine1996;334:677‐82. O'BrienB , LevineM , WillanA , GoereeR , HaleyS , BlackhouseG , et al. Economic evaluation of outpatient treatment with low‐molecular‐weight‐heparin for proximal vein thrombosis. Archives of Internal Medicine1999;159:2298‐304. ">Levine 1996</a>). Three trials were smaller (<a href="./references#CD003076-bbs2-0002" title="BoccalonH , EliasA , ChaleJJ , CadeneA , DumoulinA . Treatment of deep vein thrombosis at home: from theory to medical practice [French]. Bulletin de l'Academie Nationale de Medecine1998;182(1):101‐15. BoccalonH , EliasA , ChaleJJ , CadeneA , GabrielS . Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low‐molecular‐weight heparin: the Vascular Midi‐Pyrenees study. Archives of Internal Medicine2000;160(12):1769‐73. ">Boccalon 2000</a>; <a href="./references#CD003076-bbs2-0004" title="DaskalopoulosME , DaskalopoulouSS , TzortzisE , SfiridisP , NikolaouA , DimitroulisD , et al. Long‐term treatment of deep venous thrombosis with a low molecular weight heparin (tinzaparin): a prospective randomized trial. European Journal of Vascular and Endovascular Surgery2005;29(6):638‐50. ">Daskalopoulos 2005</a>; <a href="./references#CD003076-bbs2-0007" title="RamacciottiE , AraujoGR , LastoriaS , DietrichF , MaffeiFH , MussiNS . The efficacy and safety of enoxaparin once‐daily given partly at home, compared with unfractionated heparin given in the hospital in the treatment of proximal deep‐vein thrombosis, a Brazilian multicenter study. Blood2001;98(11):Abstract 4026. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , DietrichF . An open‐label, comparative study of the efficacy and safety of an outpatient single daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Blood2002;11:503a‐Abstract 1960. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , Dietrich‐NetoF , CLETRAT Investigators. Efficacy and safety of once‐daily enoxaparin given in the outpatient setting compared with in‐hospital unfractionated heparin for treatment of proximal lower limb deep‐vein thrombosis. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1401. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , KaraoglanDM , MichaelisW , et al. An open‐label, comparative study of the efficacy and safety of once‐daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Thrombosis Research2004;114(3):149‐53. ">Ramacciotti 2004</a>). <a href="./references#CD003076-bbs2-0002" title="BoccalonH , EliasA , ChaleJJ , CadeneA , DumoulinA . Treatment of deep vein thrombosis at home: from theory to medical practice [French]. Bulletin de l'Academie Nationale de Medecine1998;182(1):101‐15. BoccalonH , EliasA , ChaleJJ , CadeneA , GabrielS . Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low‐molecular‐weight heparin: the Vascular Midi‐Pyrenees study. Archives of Internal Medicine2000;160(12):1769‐73. ">Boccalon 2000</a> reported results on 201 randomised participants (99 home and 102 hospital); <a href="./references#CD003076-bbs2-0007" title="RamacciottiE , AraujoGR , LastoriaS , DietrichF , MaffeiFH , MussiNS . The efficacy and safety of enoxaparin once‐daily given partly at home, compared with unfractionated heparin given in the hospital in the treatment of proximal deep‐vein thrombosis, a Brazilian multicenter study. Blood2001;98(11):Abstract 4026. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , DietrichF . An open‐label, comparative study of the efficacy and safety of an outpatient single daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Blood2002;11:503a‐Abstract 1960. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , Dietrich‐NetoF , CLETRAT Investigators. Efficacy and safety of once‐daily enoxaparin given in the outpatient setting compared with in‐hospital unfractionated heparin for treatment of proximal lower limb deep‐vein thrombosis. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1401. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , KaraoglanDM , MichaelisW , et al. An open‐label, comparative study of the efficacy and safety of once‐daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Thrombosis Research2004;114(3):149‐53. ">Ramacciotti 2004</a> reported results on 104 home and 97 hospital randomised participants; and in <a href="./references#CD003076-bbs2-0004" title="DaskalopoulosME , DaskalopoulouSS , TzortzisE , SfiridisP , NikolaouA , DimitroulisD , et al. Long‐term treatment of deep venous thrombosis with a low molecular weight heparin (tinzaparin): a prospective randomized trial. European Journal of Vascular and Endovascular Surgery2005;29(6):638‐50. ">Daskalopoulos 2005</a>, investigators randomised 108 participants (55 to home and 53 to hospital). <a href="./references#CD003076-bbs2-0001" title="BäckmanK , CarlssonP , KentsonM , HansenS , EngquistL , HallertC . Deep venous thrombosis: a new task for primary health care. Scandinavian Journal of Primary Health Care2004;22(1):44‐9. ">Bäckman 2004</a> evaluated and compared direct and indirect medical costs during a three‐month period for 131 randomised participants (65 out‐patient/home and 66 in‐patient). </p> <p><a href="./references#CD003076-bbs2-0001" title="BäckmanK , CarlssonP , KentsonM , HansenS , EngquistL , HallertC . Deep venous thrombosis: a new task for primary health care. Scandinavian Journal of Primary Health Care2004;22(1):44‐9. ">Bäckman 2004</a> did not report on any of the predefined outcomes of this review other than costs; therefore we did not include this study in any meta‐analyses for these outcomes. </p> <p>The three major trials (<a href="./references#CD003076-bbs2-0003" title="ChongBH . A randomized, prospective, multicentre study comparing the efficacy, safety and cost of once‐daily enoxaparin given at home with unfractionated heparin given in hospital in the treatment of deep‐vein thrombosis. Blood2002;100(11):Abstract 2772. ChongBH , BrightonTA , BakerRI , ThurlowP , LeeCH , ASTH DS Group. Once‐daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep‐vein thrombosis. Journal of Thrombosis and Thrombolysis2005;19(3):173‐81. ">Chong 2005</a>; <a href="./references#CD003076-bbs2-0005" title="KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of patients with venous thrombosis with intravenous unfractionated heparin in hospital compared with subcutaneous low‐molecular‐weight heparin out of hospital. Annals of Hematology1996;72:A3. KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of venous thrombosis with intravenous unfractionated heparin in hospital as compared with subcutaneous low molecular weight heparin at home. New England Journal of Medicine1996;334(11):682‐7. van denBeltAGM , BossuytPMM , PrinsMH , GallusAS , BullerHR . Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis ‐ an economic evaluation. Thrombosis and Haemostasis1998;79:259‐62. ">Koopman 1996</a>; <a href="./references#CD003076-bbs2-0006" title="LevineM , GentM , HirschJ , LeclercJ , AndersonD , WeitzJ , et al. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis. New England Journal of Medicine1996;334:677‐82. O'BrienB , LevineM , WillanA , GoereeR , HaleyS , BlackhouseG , et al. Economic evaluation of outpatient treatment with low‐molecular‐weight‐heparin for proximal vein thrombosis. Archives of Internal Medicine1999;159:2298‐304. ">Levine 1996</a>) were similar in construction and results but differed in their exclusion rates (see <a href="./references#CD003076-sec-0098" title="">Characteristics of included studies</a>; further discussed in <a href="#CD003076-sec-0074">Overall completeness and applicability of evidence</a>). Of the seven trials, only <a href="./references#CD003076-bbs2-0002" title="BoccalonH , EliasA , ChaleJJ , CadeneA , DumoulinA . Treatment of deep vein thrombosis at home: from theory to medical practice [French]. Bulletin de l'Academie Nationale de Medecine1998;182(1):101‐15. BoccalonH , EliasA , ChaleJJ , CadeneA , GabrielS . Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low‐molecular‐weight heparin: the Vascular Midi‐Pyrenees study. Archives of Internal Medicine2000;160(12):1769‐73. ">Boccalon 2000</a> and <a href="./references#CD003076-bbs2-0001" title="BäckmanK , CarlssonP , KentsonM , HansenS , EngquistL , HallertC . Deep venous thrombosis: a new task for primary health care. Scandinavian Journal of Primary Health Care2004;22(1):44‐9. ">Bäckman 2004</a> used LMWH in both treatment arms; the other five used LMWH in home treatment arms and UFH in hospital treatment arms. </p> <p>See <a href="./references#CD003076-sec-0098" title="">Characteristics of included studies</a> tables for further details of the included studies. </p> </section> <section id="CD003076-sec-0056"> <h4 class="title">Excluded studies</h4> <p>For this update, we excluded an additional five studies (<a href="./references#CD003076-bbs2-0008" title="AujeskyD , RoyPM , VerschurenF , RighiniM , OsterwalderJ , EgloffM , et al. An international, randomized non‐inferiority trial of outpatient versus inpatient treatment for pulmonary embolism. Journal of General Internal Medicine2011;26(10):1220. AujeskyD , RoyPM , VerschurenF , RighiniM , OsterwalderJ , EgloffM , et al. Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open‐label, randomised, non‐inferiority trial. Lancet2011;378(9785):41‐8. ">Aujesky 2011</a>; <a href="./references#CD003076-bbs2-0021" title="HullRD , PineoGF , BrantR , LiangJ , CookR , SolymossS , et al. Home therapy of venous thrombosis with long‐term LMWH versus usual care: patient satisfaction and post‐thrombotic syndrome. American Journal of Medicine2009;122(8):762‐9. ">Hull 2009</a>; <a href="./references#CD003076-bbs2-0024" title="Modesto‐AlapontM , Nauffal‐ManzurD , Nsotegui‐BarreraE , Menendez‐VillanuevaR , BallestaA , TouzaR , et al. Can home prophylaxis for venous thromboembolism reduce mortality rates in patients with chronic obstructive pulmonary disease? [Spanish]. Archivos de Bronconeumologia2006;42(3):130‐4. ">Modesto‐Alapont 2006</a>; <a href="./references#CD003076-bbs2-0026" title="Anon . Home treatment of pulmonary embolism. http://clinicaltrials.gov/show/NCT00214929.2005. OteroR , UresandiF , JiménezD , CabezudoMA , OribeM , NauffalD , et al. Home treatment in pulmonary embolism. Thrombosis Research2010;126(1):e1‐e5. ">Otero 2010</a>; <a href="./references#CD003076-bbs2-0032" title="WilsonSJ , WellsPS , KovacsMJ , LewisGM , MartinJ , BurtonE , et al. Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial. Canadian Medical Association Journal2003;169(4):293‐8. ">Wilson 2003</a>), for a total of 26 excluded studies (<a href="./references#CD003076-bbs2-0008" title="AujeskyD , RoyPM , VerschurenF , RighiniM , OsterwalderJ , EgloffM , et al. An international, randomized non‐inferiority trial of outpatient versus inpatient treatment for pulmonary embolism. Journal of General Internal Medicine2011;26(10):1220. AujeskyD , RoyPM , VerschurenF , RighiniM , OsterwalderJ , EgloffM , et al. Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open‐label, randomised, non‐inferiority trial. Lancet2011;378(9785):41‐8. ">Aujesky 2011</a>; <a href="./references#CD003076-bbs2-0009" title="BelcaroG , NicolaidesAN , CesaroneMR , LauroraG , DeSanctisMT , IncandelaL , et al. Comparison of low molecular weight heparin, administered primarily at home, with unfractionated heparin, administered in hospital, and subcutaneous heparin, administered at home for deep‐vein thrombosis. Angiology1999;50(10):781‐7. ">Belcaro 1999</a>; <a href="./references#CD003076-bbs2-0010" title="BlattlerW , BorerW , LinderC . Outpatient and conventional treatment of acute deep vein thrombosis evaluated in a controlled single‐centre study. Phlébologie1998;51(1):41‐6. BlattlerW , BorerW , LinderC , BerganJ . Outpatient and conventional treatment of acute deep vein thrombosis evaluated in a controlled single‐centre study [Traitements ambulatoire et conventionnel de la thrombose veineuse profonde aigue: Bilan monocentrique]. Phlébologie1998;51(1):33‐9. ">Blattler 1998</a>; <a href="./references#CD003076-bbs2-0011" title="BullerH . Initial outpatient treatment of venous thromboembolism with Fondaparinux (Arixtra®): the MATISSE trials. Journal of Thrombosis and Haemostasis. 2005; Vol. 3, issue 1:Abstract P1112. BullerHR , The Matisse Investigators. Initial outpatient treatment of venous thromboembolism with fondaparinux (Arixtra(R)): the MATISSE trials. Blood. 104 2004; Vol. 104, issue 11:Abstract 705. ">Buller 2004</a>; <a href="./references#CD003076-bbs2-0012" title="ConnerC . Innohep User's meeting, Windsor. Data on file1999. ">Conner 1999</a>; <a href="./references#CD003076-bbs2-0013" title="FitzmauriceDA , HobbsFD , MurrayET , HolderRL , AllanTF , RosePE . Oral anticoagulation management in primary care with the use of computerised decision support and near‐patient testing: a randomised, controlled trial. Archives of Internal Medicine2000;160(15):2343‐8. ">Fitzmaurice 2000</a>; <a href="./references#CD003076-bbs2-0014" title="FrankD , BlattlerW . Comparison of ambulatory and inpatient treatment of acute deep venous thrombosis of the leg: subjective and economic aspects [German]. Schweizerische Medizinische Wochenschrift. Journal Suisse de Medecine1998;128(36):1328‐33. ">Frank 1998</a>; <a href="./references#CD003076-bbs2-0015" title="GoldhaberSZ , MorrisonRB , DiranLL , CreagerMA , LeeTH . Abbreviated hospitalisation for deep vein thrombosis with the use of ardeparin. Archives of Internal Medicine1998;158(21):2325‐8. ">Goldhaber 1998</a>; <a href="./references#CD003076-bbs2-0016" title="GrauE , RealE , PastorE , VicianoV , AguiloJ . Home treatment of deep vein thrombosis: a two‐years experience of a single institution. Haematologica1998;83(5):438‐41. ">Grau 1998</a>; <a href="./references#CD003076-bbs2-0017" title="GrauE , TeniasJM , RealE , MedranoJ , FerrerR , PastorE , et al. Home treatment of deep vein thrombosis with low molecular weight heparin: long‐term incidence of recurrent venous thromboembolism. American Journal of Haematology2001;67(1):10‐4. ">Grau 2001</a>; <a href="./references#CD003076-bbs2-0018" title="GreenES , RhodesS , BondS , ThomsonS , TroughtonAH . Outpatient treatment of deep vein thrombosis using low molecular weight heparin. British Journal of Haematology1998;101(Suppl 1):Abstract 234. ">Green 1998</a>; <a href="./references#CD003076-bbs2-0019" title="HullRD , PineoGF , FrancisC , BergqvistD , FelleniusC , SoderbergK , et al. Low‐molecular‐weight heparin prophylaxis using dalteparin extended out‐of‐hospital vs in‐hospital warfarin/out‐of‐hospital placebo in hip arthroplasty patients: a double‐blind, randomized comparison. North American Fragmin Trial Investigators. Archives of Internal Medicine2000;160(14):2208‐15. ">Hull 2000</a>; <a href="./references#CD003076-bbs2-0020" title="HullRD , PineoGF , MahAF . Does rebound exist? A comparison of venous thromboembolic (VTE) event rates in the post‐treatment period for patients randomized to long‐term low‐molecular‐weight heparin (LMWH) versus warfarin sodium. Blood. 100 2002; Vol. 100, issue 11:Abstract 1951. ">Hull 2002</a>; <a href="./references#CD003076-bbs2-0021" title="HullRD , PineoGF , BrantR , LiangJ , CookR , SolymossS , et al. Home therapy of venous thrombosis with long‐term LMWH versus usual care: patient satisfaction and post‐thrombotic syndrome. American Journal of Medicine2009;122(8):762‐9. ">Hull 2009</a>; <a href="./references#CD003076-bbs2-0022" title="LindmarkerP , HolstromM . Use of low molecular weight heparin (dalteparin), once daily, for the treatment of deep vein thrombosis. A feasibility and health economic study in an outpatient setting. Swedish Venous Thrombosis Dalteparin Trial Group. Journal of Internal Medicine1996;240(6):395‐401. ">Lindmarker 1996</a>; <a href="./references#CD003076-bbs2-0023" title="MilesJ , O'ShaugnesseyD , WimperisJ . Outpatient management of DVT in the United Kingdom. Presentation to American Thoracic Society. 1998. ">Miles 1998</a>; <a href="./references#CD003076-bbs2-0024" title="Modesto‐AlapontM , Nauffal‐ManzurD , Nsotegui‐BarreraE , Menendez‐VillanuevaR , BallestaA , TouzaR , et al. Can home prophylaxis for venous thromboembolism reduce mortality rates in patients with chronic obstructive pulmonary disease? [Spanish]. Archivos de Bronconeumologia2006;42(3):130‐4. ">Modesto‐Alapont 2006</a>; <a href="./references#CD003076-bbs2-0025" title="O'ShaughnessyDF , ToveyC , MillerALC , O'NeillV , RanaPS , AkbarS , et al. Outpatient management of deep vein thrombosis. Journal of Accident and Emergency Medicine1998;15(5):292‐3. ">O'Shaugnessy 1998</a>; <a href="./references#CD003076-bbs2-0026" title="Anon . Home treatment of pulmonary embolism. http://clinicaltrials.gov/show/NCT00214929.2005. OteroR , UresandiF , JiménezD , CabezudoMA , OribeM , NauffalD , et al. Home treatment in pulmonary embolism. Thrombosis Research2010;126(1):e1‐e5. ">Otero 2010</a>; <a href="./references#CD003076-bbs2-0027" title="PineoGF , HullRD , MahAF , LiteI . Does rebound exist? A comparison of venous thromboembolic event rates in the post‐treatment period for patients randomized to long‐term low‐molecular‐weight heparin vs. warfarin sodium. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1882. ">Pineo 2003</a>; <a href="./references#CD003076-bbs2-0028" title="RymesNL , LesterW , ConnorC , ChakrabatiS , FeganCD . Outpatient management of DVT using LMWH and a hospital outreach service. Clinical and Laboratory Haematology2002;24(3):165‐70. ">Rymes 2002</a>; <a href="./references#CD003076-bbs2-0029" title="TingSBN , ZiegenbeinRW , GanTE , CatalanoJV , MonagleP , SilversJ , et al. Dalteparin for deep vein thrombosis: a hospital‐in‐the‐home program. Medical Journal of Australia1998;168(6):272‐6. ">Ting 1998</a>; <a href="./references#CD003076-bbs2-0030" title="WellsPS , KovacsMJ , BormanisJ , ForgieMA , GoudieD , MorrowB , et al. Expanding eligibility for outpatient treatment of deep vein thrombosis and pulmonary embolism with low‐molecular‐weight heparin: a comparison of patient self‐injection with homecare injection. Archives of Internal Medicine1998;158(16):1809‐12. ">Wells 1998</a>; <a href="./references#CD003076-bbs2-0031" title="WhiteRH , McCurdySA , vonMarensdorffH , WoodruffDEJ , LeftgoffL . Home prothrombin time monitoring after the initiation of warfarin therapy. A randomised, prospective study. Annals of Internal Medicine1989;111(9):730‐7. ">White 1989</a>; <a href="./references#CD003076-bbs2-0032" title="WilsonSJ , WellsPS , KovacsMJ , LewisGM , MartinJ , BurtonE , et al. Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial. Canadian Medical Association Journal2003;169(4):293‐8. ">Wilson 2003</a>; <a href="./references#CD003076-bbs2-0033" title="WimperisJZ , PoutG , DilksG , WilsonP , ClarkeJ , JenkinsP , et al. Significant bed savings resulting from outpatient management of deep vein thrombosis with low molecular weight heparin. British Journal of Haematology1998;101(Suppl 1):Abstract 231. ">Wimperis 1998</a>). </p> <p>Eight were uncontrolled studies (<a href="./references#CD003076-bbs2-0012" title="ConnerC . Innohep User's meeting, Windsor. Data on file1999. ">Conner 1999</a>; <a href="./references#CD003076-bbs2-0016" title="GrauE , RealE , PastorE , VicianoV , AguiloJ . Home treatment of deep vein thrombosis: a two‐years experience of a single institution. Haematologica1998;83(5):438‐41. ">Grau 1998</a>; <a href="./references#CD003076-bbs2-0018" title="GreenES , RhodesS , BondS , ThomsonS , TroughtonAH . Outpatient treatment of deep vein thrombosis using low molecular weight heparin. British Journal of Haematology1998;101(Suppl 1):Abstract 234. ">Green 1998</a>; <a href="./references#CD003076-bbs2-0022" title="LindmarkerP , HolstromM . Use of low molecular weight heparin (dalteparin), once daily, for the treatment of deep vein thrombosis. A feasibility and health economic study in an outpatient setting. Swedish Venous Thrombosis Dalteparin Trial Group. Journal of Internal Medicine1996;240(6):395‐401. ">Lindmarker 1996</a>; <a href="./references#CD003076-bbs2-0023" title="MilesJ , O'ShaugnesseyD , WimperisJ . Outpatient management of DVT in the United Kingdom. Presentation to American Thoracic Society. 1998. ">Miles 1998</a>; <a href="./references#CD003076-bbs2-0025" title="O'ShaughnessyDF , ToveyC , MillerALC , O'NeillV , RanaPS , AkbarS , et al. Outpatient management of deep vein thrombosis. Journal of Accident and Emergency Medicine1998;15(5):292‐3. ">O'Shaugnessy 1998</a>; <a href="./references#CD003076-bbs2-0029" title="TingSBN , ZiegenbeinRW , GanTE , CatalanoJV , MonagleP , SilversJ , et al. Dalteparin for deep vein thrombosis: a hospital‐in‐the‐home program. Medical Journal of Australia1998;168(6):272‐6. ">Ting 1998</a>; <a href="./references#CD003076-bbs2-0033" title="WimperisJZ , PoutG , DilksG , WilsonP , ClarkeJ , JenkinsP , et al. Significant bed savings resulting from outpatient management of deep vein thrombosis with low molecular weight heparin. British Journal of Haematology1998;101(Suppl 1):Abstract 231. ">Wimperis 1998</a>), and two were retrospective studies (<a href="./references#CD003076-bbs2-0017" title="GrauE , TeniasJM , RealE , MedranoJ , FerrerR , PastorE , et al. Home treatment of deep vein thrombosis with low molecular weight heparin: long‐term incidence of recurrent venous thromboembolism. American Journal of Haematology2001;67(1):10‐4. ">Grau 2001</a>; <a href="./references#CD003076-bbs2-0028" title="RymesNL , LesterW , ConnorC , ChakrabatiS , FeganCD . Outpatient management of DVT using LMWH and a hospital outreach service. Clinical and Laboratory Haematology2002;24(3):165‐70. ">Rymes 2002</a>). We excluded the remaining 16 trials for a variety of reasons. We excluded two reported controlled trials because participants were not actually randomised but instead were treated according to their expressed therapeutic preferences (<a href="./references#CD003076-bbs2-0010" title="BlattlerW , BorerW , LinderC . Outpatient and conventional treatment of acute deep vein thrombosis evaluated in a controlled single‐centre study. Phlébologie1998;51(1):41‐6. BlattlerW , BorerW , LinderC , BerganJ . Outpatient and conventional treatment of acute deep vein thrombosis evaluated in a controlled single‐centre study [Traitements ambulatoire et conventionnel de la thrombose veineuse profonde aigue: Bilan monocentrique]. Phlébologie1998;51(1):33‐9. ">Blattler 1998</a>; <a href="./references#CD003076-bbs2-0014" title="FrankD , BlattlerW . Comparison of ambulatory and inpatient treatment of acute deep venous thrombosis of the leg: subjective and economic aspects [German]. Schweizerische Medizinische Wochenschrift. Journal Suisse de Medecine1998;128(36):1328‐33. ">Frank 1998</a>). We excluded <a href="./references#CD003076-bbs2-0030" title="WellsPS , KovacsMJ , BormanisJ , ForgieMA , GoudieD , MorrowB , et al. Expanding eligibility for outpatient treatment of deep vein thrombosis and pulmonary embolism with low‐molecular‐weight heparin: a comparison of patient self‐injection with homecare injection. Archives of Internal Medicine1998;158(16):1809‐12. ">Wells 1998</a> because this study compared patient‐administered versus nurse‐administered injections rather than the location of treatment; <a href="./references#CD003076-bbs2-0015" title="GoldhaberSZ , MorrisonRB , DiranLL , CreagerMA , LeeTH . Abbreviated hospitalisation for deep vein thrombosis with the use of ardeparin. Archives of Internal Medicine1998;158(21):2325‐8. ">Goldhaber 1998</a> because participants randomised to treatment with LMWH in a home setting were first required to be treated in hospital for several days; <a href="./references#CD003076-bbs2-0026" title="Anon . Home treatment of pulmonary embolism. http://clinicaltrials.gov/show/NCT00214929.2005. OteroR , UresandiF , JiménezD , CabezudoMA , OribeM , NauffalD , et al. Home treatment in pulmonary embolism. Thrombosis Research2010;126(1):e1‐e5. ">Otero 2010</a> and <a href="./references#CD003076-bbs2-0008" title="AujeskyD , RoyPM , VerschurenF , RighiniM , OsterwalderJ , EgloffM , et al. An international, randomized non‐inferiority trial of outpatient versus inpatient treatment for pulmonary embolism. Journal of General Internal Medicine2011;26(10):1220. AujeskyD , RoyPM , VerschurenF , RighiniM , OsterwalderJ , EgloffM , et al. Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open‐label, randomised, non‐inferiority trial. Lancet2011;378(9785):41‐8. ">Aujesky 2011</a> because these studies focussed on PE ‐ not DVT; <a href="./references#CD003076-bbs2-0009" title="BelcaroG , NicolaidesAN , CesaroneMR , LauroraG , DeSanctisMT , IncandelaL , et al. Comparison of low molecular weight heparin, administered primarily at home, with unfractionated heparin, administered in hospital, and subcutaneous heparin, administered at home for deep‐vein thrombosis. Angiology1999;50(10):781‐7. ">Belcaro 1999</a> because this was primarily a trial of formulations of heparin rather than a trial of home versus hospital treatment; <a href="./references#CD003076-bbs2-0019" title="HullRD , PineoGF , FrancisC , BergqvistD , FelleniusC , SoderbergK , et al. Low‐molecular‐weight heparin prophylaxis using dalteparin extended out‐of‐hospital vs in‐hospital warfarin/out‐of‐hospital placebo in hip arthroplasty patients: a double‐blind, randomized comparison. North American Fragmin Trial Investigators. Archives of Internal Medicine2000;160(14):2208‐15. ">Hull 2000</a> and <a href="./references#CD003076-bbs2-0024" title="Modesto‐AlapontM , Nauffal‐ManzurD , Nsotegui‐BarreraE , Menendez‐VillanuevaR , BallestaA , TouzaR , et al. Can home prophylaxis for venous thromboembolism reduce mortality rates in patients with chronic obstructive pulmonary disease? [Spanish]. Archivos de Bronconeumologia2006;42(3):130‐4. ">Modesto‐Alapont 2006</a> because investigators were concerned with prophylactic regimens including LMWH for patients undergoing hip arthroplasty and for those with VTE in obstructive pulmonary disease, respectively; <a href="./references#CD003076-bbs2-0027" title="PineoGF , HullRD , MahAF , LiteI . Does rebound exist? A comparison of venous thromboembolic event rates in the post‐treatment period for patients randomized to long‐term low‐molecular‐weight heparin vs. warfarin sodium. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1882. ">Pineo 2003</a> and <a href="./references#CD003076-bbs2-0020" title="HullRD , PineoGF , MahAF . Does rebound exist? A comparison of venous thromboembolic (VTE) event rates in the post‐treatment period for patients randomized to long‐term low‐molecular‐weight heparin (LMWH) versus warfarin sodium. Blood. 100 2002; Vol. 100, issue 11:Abstract 1951. ">Hull 2002</a> because they investigated two protocols on long‐term effects of LMWH treatment ‐ not location; and two other trials because they did not include in‐patient arms ‐ <a href="./references#CD003076-bbs2-0032" title="WilsonSJ , WellsPS , KovacsMJ , LewisGM , MartinJ , BurtonE , et al. Comparing the quality of oral anticoagulant management by anticoagulation clinics and by family physicians: a randomized controlled trial. Canadian Medical Association Journal2003;169(4):293‐8. ">Wilson 2003</a> compared anticoagulant clinics versus family clinics, and <a href="./references#CD003076-bbs2-0021" title="HullRD , PineoGF , BrantR , LiangJ , CookR , SolymossS , et al. Home therapy of venous thrombosis with long‐term LMWH versus usual care: patient satisfaction and post‐thrombotic syndrome. American Journal of Medicine2009;122(8):762‐9. ">Hull 2009</a> compared long‐term subcutaneous tinzaparin versus initial tinzaparin followed by long‐term warfarin in the community as opposed to home patients versus in‐patients. <a href="./references#CD003076-bbs2-0031" title="WhiteRH , McCurdySA , vonMarensdorffH , WoodruffDEJ , LeftgoffL . Home prothrombin time monitoring after the initiation of warfarin therapy. A randomised, prospective study. Annals of Internal Medicine1989;111(9):730‐7. ">White 1989</a> and <a href="./references#CD003076-bbs2-0013" title="FitzmauriceDA , HobbsFD , MurrayET , HolderRL , AllanTF , RosePE . Oral anticoagulation management in primary care with the use of computerised decision support and near‐patient testing: a randomised, controlled trial. Archives of Internal Medicine2000;160(15):2343‐8. ">Fitzmaurice 2000</a> were concerned with monitoring oral anticoagulation at home or in general practitioner (GP) surgery. <a href="./references#CD003076-bbs2-0011" title="BullerH . Initial outpatient treatment of venous thromboembolism with Fondaparinux (Arixtra®): the MATISSE trials. Journal of Thrombosis and Haemostasis. 2005; Vol. 3, issue 1:Abstract P1112. BullerHR , The Matisse Investigators. Initial outpatient treatment of venous thromboembolism with fondaparinux (Arixtra(R)): the MATISSE trials. Blood. 104 2004; Vol. 104, issue 11:Abstract 705. ">Buller 2004</a> compared once‐daily LMWH versus twice‐daily doses in the out‐patient setting, and LMWH versus UFH in the out‐patient setting ‐ not hospital versus home. </p> <p>See also <a href="./references#CD003076-sec-0099" title="">Characteristics of excluded studies</a>. </p> </section> </section> <section id="CD003076-sec-0057"> <h3 class="title">Risk of bias in included studies</h3> <p><a href="#CD003076-fig-0002">Figure 2</a> gives an overall view of our assessment of included studies' risk of bias, and <a href="#CD003076-fig-0003">Figure 3</a> shows the 'Risk of bias' summary presented as percentages across all included studies. See also <a href="./references#CD003076-sec-0098" title="">Characteristics of included studies</a>. </p> <div class="figure" id="CD003076-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD003076-fig-0002" src="/cdsr/doi/10.1002/14651858.CD003076.pub3/media/CDSR/CD003076/image_n/nCD003076-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD003076-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD003076-fig-0003" src="/cdsr/doi/10.1002/14651858.CD003076.pub3/media/CDSR/CD003076/image_n/nCD003076-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD003076-sec-0058"> <h4 class="title">Allocation</h4> <p>We considered the following methods of allocation concealment adequate.</p> <p> <ul id="CD003076-list-0006"> <li> <p>Central allocation, including telephone randomisation.</p> </li> <li> <p>Use of sequentially numbered, opaque, sealed envelopes.</p> </li> </ul> </p> <p>We deemed risk of bias as low if study authors described one of these methods. We deemed risk of bias as unclear if researchers described the trial as randomised but did not describe the method used for allocation concealment. </p> <p>All included trials were reported as randomised controlled trials (RCTs). Random sequence generation was unclear in six studies (<a href="./references#CD003076-bbs2-0001" title="BäckmanK , CarlssonP , KentsonM , HansenS , EngquistL , HallertC . Deep venous thrombosis: a new task for primary health care. Scandinavian Journal of Primary Health Care2004;22(1):44‐9. ">Bäckman 2004</a>; <a href="./references#CD003076-bbs2-0002" title="BoccalonH , EliasA , ChaleJJ , CadeneA , DumoulinA . Treatment of deep vein thrombosis at home: from theory to medical practice [French]. Bulletin de l'Academie Nationale de Medecine1998;182(1):101‐15. BoccalonH , EliasA , ChaleJJ , CadeneA , GabrielS . Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low‐molecular‐weight heparin: the Vascular Midi‐Pyrenees study. Archives of Internal Medicine2000;160(12):1769‐73. ">Boccalon 2000</a>; <a href="./references#CD003076-bbs2-0003" title="ChongBH . A randomized, prospective, multicentre study comparing the efficacy, safety and cost of once‐daily enoxaparin given at home with unfractionated heparin given in hospital in the treatment of deep‐vein thrombosis. Blood2002;100(11):Abstract 2772. ChongBH , BrightonTA , BakerRI , ThurlowP , LeeCH , ASTH DS Group. Once‐daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep‐vein thrombosis. Journal of Thrombosis and Thrombolysis2005;19(3):173‐81. ">Chong 2005</a>; <a href="./references#CD003076-bbs2-0005" title="KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of patients with venous thrombosis with intravenous unfractionated heparin in hospital compared with subcutaneous low‐molecular‐weight heparin out of hospital. Annals of Hematology1996;72:A3. KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of venous thrombosis with intravenous unfractionated heparin in hospital as compared with subcutaneous low molecular weight heparin at home. New England Journal of Medicine1996;334(11):682‐7. van denBeltAGM , BossuytPMM , PrinsMH , GallusAS , BullerHR . Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis ‐ an economic evaluation. Thrombosis and Haemostasis1998;79:259‐62. ">Koopman 1996</a>; <a href="./references#CD003076-bbs2-0006" title="LevineM , GentM , HirschJ , LeclercJ , AndersonD , WeitzJ , et al. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis. New England Journal of Medicine1996;334:677‐82. O'BrienB , LevineM , WillanA , GoereeR , HaleyS , BlackhouseG , et al. Economic evaluation of outpatient treatment with low‐molecular‐weight‐heparin for proximal vein thrombosis. Archives of Internal Medicine1999;159:2298‐304. ">Levine 1996</a>; <a href="./references#CD003076-bbs2-0007" title="RamacciottiE , AraujoGR , LastoriaS , DietrichF , MaffeiFH , MussiNS . The efficacy and safety of enoxaparin once‐daily given partly at home, compared with unfractionated heparin given in the hospital in the treatment of proximal deep‐vein thrombosis, a Brazilian multicenter study. Blood2001;98(11):Abstract 4026. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , DietrichF . An open‐label, comparative study of the efficacy and safety of an outpatient single daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Blood2002;11:503a‐Abstract 1960. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , Dietrich‐NetoF , CLETRAT Investigators. Efficacy and safety of once‐daily enoxaparin given in the outpatient setting compared with in‐hospital unfractionated heparin for treatment of proximal lower limb deep‐vein thrombosis. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1401. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , KaraoglanDM , MichaelisW , et al. An open‐label, comparative study of the efficacy and safety of once‐daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Thrombosis Research2004;114(3):149‐53. ">Ramacciotti 2004</a>) but was adequate in a single trial (<a href="./references#CD003076-bbs2-0004" title="DaskalopoulosME , DaskalopoulouSS , TzortzisE , SfiridisP , NikolaouA , DimitroulisD , et al. Long‐term treatment of deep venous thrombosis with a low molecular weight heparin (tinzaparin): a prospective randomized trial. European Journal of Vascular and Endovascular Surgery2005;29(6):638‐50. ">Daskalopoulos 2005</a>) as these investigators reported using a computerised process. </p> <p>Four trials adequately concealed allocation (<a href="./references#CD003076-bbs2-0001" title="BäckmanK , CarlssonP , KentsonM , HansenS , EngquistL , HallertC . Deep venous thrombosis: a new task for primary health care. Scandinavian Journal of Primary Health Care2004;22(1):44‐9. ">Bäckman 2004</a>; <a href="./references#CD003076-bbs2-0002" title="BoccalonH , EliasA , ChaleJJ , CadeneA , DumoulinA . Treatment of deep vein thrombosis at home: from theory to medical practice [French]. Bulletin de l'Academie Nationale de Medecine1998;182(1):101‐15. BoccalonH , EliasA , ChaleJJ , CadeneA , GabrielS . Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low‐molecular‐weight heparin: the Vascular Midi‐Pyrenees study. Archives of Internal Medicine2000;160(12):1769‐73. ">Boccalon 2000</a>; <a href="./references#CD003076-bbs2-0005" title="KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of patients with venous thrombosis with intravenous unfractionated heparin in hospital compared with subcutaneous low‐molecular‐weight heparin out of hospital. Annals of Hematology1996;72:A3. KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of venous thrombosis with intravenous unfractionated heparin in hospital as compared with subcutaneous low molecular weight heparin at home. New England Journal of Medicine1996;334(11):682‐7. van denBeltAGM , BossuytPMM , PrinsMH , GallusAS , BullerHR . Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis ‐ an economic evaluation. Thrombosis and Haemostasis1998;79:259‐62. ">Koopman 1996</a>; <a href="./references#CD003076-bbs2-0006" title="LevineM , GentM , HirschJ , LeclercJ , AndersonD , WeitzJ , et al. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis. New England Journal of Medicine1996;334:677‐82. O'BrienB , LevineM , WillanA , GoereeR , HaleyS , BlackhouseG , et al. Economic evaluation of outpatient treatment with low‐molecular‐weight‐heparin for proximal vein thrombosis. Archives of Internal Medicine1999;159:2298‐304. ">Levine 1996</a>). <a href="./references#CD003076-bbs2-0004" title="DaskalopoulosME , DaskalopoulouSS , TzortzisE , SfiridisP , NikolaouA , DimitroulisD , et al. Long‐term treatment of deep venous thrombosis with a low molecular weight heparin (tinzaparin): a prospective randomized trial. European Journal of Vascular and Endovascular Surgery2005;29(6):638‐50. ">Daskalopoulos 2005</a> did not report the method used, and <a href="./references#CD003076-bbs2-0003" title="ChongBH . A randomized, prospective, multicentre study comparing the efficacy, safety and cost of once‐daily enoxaparin given at home with unfractionated heparin given in hospital in the treatment of deep‐vein thrombosis. Blood2002;100(11):Abstract 2772. ChongBH , BrightonTA , BakerRI , ThurlowP , LeeCH , ASTH DS Group. Once‐daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep‐vein thrombosis. Journal of Thrombosis and Thrombolysis2005;19(3):173‐81. ">Chong 2005</a> did not report allocation concealment, so we rated both as having unclear risk of bias. In the <a href="./references#CD003076-bbs2-0007" title="RamacciottiE , AraujoGR , LastoriaS , DietrichF , MaffeiFH , MussiNS . The efficacy and safety of enoxaparin once‐daily given partly at home, compared with unfractionated heparin given in the hospital in the treatment of proximal deep‐vein thrombosis, a Brazilian multicenter study. Blood2001;98(11):Abstract 4026. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , DietrichF . An open‐label, comparative study of the efficacy and safety of an outpatient single daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Blood2002;11:503a‐Abstract 1960. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , Dietrich‐NetoF , CLETRAT Investigators. Efficacy and safety of once‐daily enoxaparin given in the outpatient setting compared with in‐hospital unfractionated heparin for treatment of proximal lower limb deep‐vein thrombosis. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1401. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , KaraoglanDM , MichaelisW , et al. An open‐label, comparative study of the efficacy and safety of once‐daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Thrombosis Research2004;114(3):149‐53. ">Ramacciotti 2004</a> study, researchers performed randomisation by using blocks in an 'open manner'; we rated this study as having high risk of bias. </p> </section> <section id="CD003076-sec-0059"> <h4 class="title">Blinding</h4> <p>Blinding refers to whether participants and study personnel knew which participants were treated in hospital, and which received treatment at home. By the nature of this study, blinding was never going to be easy to achieve. Five studies were open, non‐blinded studies (<a href="./references#CD003076-bbs2-0003" title="ChongBH . A randomized, prospective, multicentre study comparing the efficacy, safety and cost of once‐daily enoxaparin given at home with unfractionated heparin given in hospital in the treatment of deep‐vein thrombosis. Blood2002;100(11):Abstract 2772. ChongBH , BrightonTA , BakerRI , ThurlowP , LeeCH , ASTH DS Group. Once‐daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep‐vein thrombosis. Journal of Thrombosis and Thrombolysis2005;19(3):173‐81. ">Chong 2005</a>; <a href="./references#CD003076-bbs2-0004" title="DaskalopoulosME , DaskalopoulouSS , TzortzisE , SfiridisP , NikolaouA , DimitroulisD , et al. Long‐term treatment of deep venous thrombosis with a low molecular weight heparin (tinzaparin): a prospective randomized trial. European Journal of Vascular and Endovascular Surgery2005;29(6):638‐50. ">Daskalopoulos 2005</a>; <a href="./references#CD003076-bbs2-0005" title="KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of patients with venous thrombosis with intravenous unfractionated heparin in hospital compared with subcutaneous low‐molecular‐weight heparin out of hospital. Annals of Hematology1996;72:A3. KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of venous thrombosis with intravenous unfractionated heparin in hospital as compared with subcutaneous low molecular weight heparin at home. New England Journal of Medicine1996;334(11):682‐7. van denBeltAGM , BossuytPMM , PrinsMH , GallusAS , BullerHR . Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis ‐ an economic evaluation. Thrombosis and Haemostasis1998;79:259‐62. ">Koopman 1996</a>; <a href="./references#CD003076-bbs2-0006" title="LevineM , GentM , HirschJ , LeclercJ , AndersonD , WeitzJ , et al. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis. New England Journal of Medicine1996;334:677‐82. O'BrienB , LevineM , WillanA , GoereeR , HaleyS , BlackhouseG , et al. Economic evaluation of outpatient treatment with low‐molecular‐weight‐heparin for proximal vein thrombosis. Archives of Internal Medicine1999;159:2298‐304. ">Levine 1996</a>; <a href="./references#CD003076-bbs2-0007" title="RamacciottiE , AraujoGR , LastoriaS , DietrichF , MaffeiFH , MussiNS . The efficacy and safety of enoxaparin once‐daily given partly at home, compared with unfractionated heparin given in the hospital in the treatment of proximal deep‐vein thrombosis, a Brazilian multicenter study. Blood2001;98(11):Abstract 4026. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , DietrichF . An open‐label, comparative study of the efficacy and safety of an outpatient single daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Blood2002;11:503a‐Abstract 1960. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , Dietrich‐NetoF , CLETRAT Investigators. Efficacy and safety of once‐daily enoxaparin given in the outpatient setting compared with in‐hospital unfractionated heparin for treatment of proximal lower limb deep‐vein thrombosis. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1401. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , KaraoglanDM , MichaelisW , et al. An open‐label, comparative study of the efficacy and safety of once‐daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Thrombosis Research2004;114(3):149‐53. ">Ramacciotti 2004</a>); we judged them to be at high risk of bias. Participants in <a href="./references#CD003076-bbs2-0001" title="BäckmanK , CarlssonP , KentsonM , HansenS , EngquistL , HallertC . Deep venous thrombosis: a new task for primary health care. Scandinavian Journal of Primary Health Care2004;22(1):44‐9. ">Bäckman 2004</a> were allowed to change their assigned treatment or to leave the study after randomisation, but we determined the risk of performance bias as low for the outcomes of this study. Although <a href="./references#CD003076-bbs2-0002" title="BoccalonH , EliasA , ChaleJJ , CadeneA , DumoulinA . Treatment of deep vein thrombosis at home: from theory to medical practice [French]. Bulletin de l'Academie Nationale de Medecine1998;182(1):101‐15. BoccalonH , EliasA , ChaleJJ , CadeneA , GabrielS . Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low‐molecular‐weight heparin: the Vascular Midi‐Pyrenees study. Archives of Internal Medicine2000;160(12):1769‐73. ">Boccalon 2000</a> reported no blinding of participants or personnel, both groups received the same treatment. All participants received an oral anticoagulant for the first three days. The review authors deemed that outcomes were unlikely to have been affected by lack of blinding of participants or personnel, and so we judged this trial to be at low risk of bias. </p> <p>Four studies had independent outcome assessors, and we deemed them to have low risk of detection bias (<a href="./references#CD003076-bbs2-0003" title="ChongBH . A randomized, prospective, multicentre study comparing the efficacy, safety and cost of once‐daily enoxaparin given at home with unfractionated heparin given in hospital in the treatment of deep‐vein thrombosis. Blood2002;100(11):Abstract 2772. ChongBH , BrightonTA , BakerRI , ThurlowP , LeeCH , ASTH DS Group. Once‐daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep‐vein thrombosis. Journal of Thrombosis and Thrombolysis2005;19(3):173‐81. ">Chong 2005</a>; <a href="./references#CD003076-bbs2-0004" title="DaskalopoulosME , DaskalopoulouSS , TzortzisE , SfiridisP , NikolaouA , DimitroulisD , et al. Long‐term treatment of deep venous thrombosis with a low molecular weight heparin (tinzaparin): a prospective randomized trial. European Journal of Vascular and Endovascular Surgery2005;29(6):638‐50. ">Daskalopoulos 2005</a>; <a href="./references#CD003076-bbs2-0005" title="KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of patients with venous thrombosis with intravenous unfractionated heparin in hospital compared with subcutaneous low‐molecular‐weight heparin out of hospital. Annals of Hematology1996;72:A3. KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of venous thrombosis with intravenous unfractionated heparin in hospital as compared with subcutaneous low molecular weight heparin at home. New England Journal of Medicine1996;334(11):682‐7. van denBeltAGM , BossuytPMM , PrinsMH , GallusAS , BullerHR . Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis ‐ an economic evaluation. Thrombosis and Haemostasis1998;79:259‐62. ">Koopman 1996</a>; <a href="./references#CD003076-bbs2-0006" title="LevineM , GentM , HirschJ , LeclercJ , AndersonD , WeitzJ , et al. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis. New England Journal of Medicine1996;334:677‐82. O'BrienB , LevineM , WillanA , GoereeR , HaleyS , BlackhouseG , et al. Economic evaluation of outpatient treatment with low‐molecular‐weight‐heparin for proximal vein thrombosis. Archives of Internal Medicine1999;159:2298‐304. ">Levine 1996</a>). Three studies did not report blinding of outcome assessors; therefore we deemed these studies to be at high risk of detection bias (<a href="./references#CD003076-bbs2-0001" title="BäckmanK , CarlssonP , KentsonM , HansenS , EngquistL , HallertC . Deep venous thrombosis: a new task for primary health care. Scandinavian Journal of Primary Health Care2004;22(1):44‐9. ">Bäckman 2004</a>; <a href="./references#CD003076-bbs2-0002" title="BoccalonH , EliasA , ChaleJJ , CadeneA , DumoulinA . Treatment of deep vein thrombosis at home: from theory to medical practice [French]. Bulletin de l'Academie Nationale de Medecine1998;182(1):101‐15. BoccalonH , EliasA , ChaleJJ , CadeneA , GabrielS . Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low‐molecular‐weight heparin: the Vascular Midi‐Pyrenees study. Archives of Internal Medicine2000;160(12):1769‐73. ">Boccalon 2000</a>; <a href="./references#CD003076-bbs2-0007" title="RamacciottiE , AraujoGR , LastoriaS , DietrichF , MaffeiFH , MussiNS . The efficacy and safety of enoxaparin once‐daily given partly at home, compared with unfractionated heparin given in the hospital in the treatment of proximal deep‐vein thrombosis, a Brazilian multicenter study. Blood2001;98(11):Abstract 4026. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , DietrichF . An open‐label, comparative study of the efficacy and safety of an outpatient single daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Blood2002;11:503a‐Abstract 1960. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , Dietrich‐NetoF , CLETRAT Investigators. Efficacy and safety of once‐daily enoxaparin given in the outpatient setting compared with in‐hospital unfractionated heparin for treatment of proximal lower limb deep‐vein thrombosis. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1401. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , KaraoglanDM , MichaelisW , et al. An open‐label, comparative study of the efficacy and safety of once‐daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Thrombosis Research2004;114(3):149‐53. ">Ramacciotti 2004</a>). </p> </section> <section id="CD003076-sec-0060"> <h4 class="title">Incomplete outcome data</h4> <p>Five of the seven included studies either reported on all participants or adequately described their loss to follow‐up; we rated them as low risk (<a href="./references#CD003076-bbs2-0001" title="BäckmanK , CarlssonP , KentsonM , HansenS , EngquistL , HallertC . Deep venous thrombosis: a new task for primary health care. Scandinavian Journal of Primary Health Care2004;22(1):44‐9. ">Bäckman 2004</a>; <a href="./references#CD003076-bbs2-0003" title="ChongBH . A randomized, prospective, multicentre study comparing the efficacy, safety and cost of once‐daily enoxaparin given at home with unfractionated heparin given in hospital in the treatment of deep‐vein thrombosis. Blood2002;100(11):Abstract 2772. ChongBH , BrightonTA , BakerRI , ThurlowP , LeeCH , ASTH DS Group. Once‐daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep‐vein thrombosis. Journal of Thrombosis and Thrombolysis2005;19(3):173‐81. ">Chong 2005</a>; <a href="./references#CD003076-bbs2-0004" title="DaskalopoulosME , DaskalopoulouSS , TzortzisE , SfiridisP , NikolaouA , DimitroulisD , et al. Long‐term treatment of deep venous thrombosis with a low molecular weight heparin (tinzaparin): a prospective randomized trial. European Journal of Vascular and Endovascular Surgery2005;29(6):638‐50. ">Daskalopoulos 2005</a>; <a href="./references#CD003076-bbs2-0005" title="KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of patients with venous thrombosis with intravenous unfractionated heparin in hospital compared with subcutaneous low‐molecular‐weight heparin out of hospital. Annals of Hematology1996;72:A3. KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of venous thrombosis with intravenous unfractionated heparin in hospital as compared with subcutaneous low molecular weight heparin at home. New England Journal of Medicine1996;334(11):682‐7. van denBeltAGM , BossuytPMM , PrinsMH , GallusAS , BullerHR . Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis ‐ an economic evaluation. Thrombosis and Haemostasis1998;79:259‐62. ">Koopman 1996</a>; <a href="./references#CD003076-bbs2-0006" title="LevineM , GentM , HirschJ , LeclercJ , AndersonD , WeitzJ , et al. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis. New England Journal of Medicine1996;334:677‐82. O'BrienB , LevineM , WillanA , GoereeR , HaleyS , BlackhouseG , et al. Economic evaluation of outpatient treatment with low‐molecular‐weight‐heparin for proximal vein thrombosis. Archives of Internal Medicine1999;159:2298‐304. ">Levine 1996</a>). <a href="./references#CD003076-bbs2-0007" title="RamacciottiE , AraujoGR , LastoriaS , DietrichF , MaffeiFH , MussiNS . The efficacy and safety of enoxaparin once‐daily given partly at home, compared with unfractionated heparin given in the hospital in the treatment of proximal deep‐vein thrombosis, a Brazilian multicenter study. Blood2001;98(11):Abstract 4026. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , DietrichF . An open‐label, comparative study of the efficacy and safety of an outpatient single daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Blood2002;11:503a‐Abstract 1960. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , Dietrich‐NetoF , CLETRAT Investigators. Efficacy and safety of once‐daily enoxaparin given in the outpatient setting compared with in‐hospital unfractionated heparin for treatment of proximal lower limb deep‐vein thrombosis. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1401. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , KaraoglanDM , MichaelisW , et al. An open‐label, comparative study of the efficacy and safety of once‐daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Thrombosis Research2004;114(3):149‐53. ">Ramacciotti 2004</a> and <a href="./references#CD003076-bbs2-0002" title="BoccalonH , EliasA , ChaleJJ , CadeneA , DumoulinA . Treatment of deep vein thrombosis at home: from theory to medical practice [French]. Bulletin de l'Academie Nationale de Medecine1998;182(1):101‐15. BoccalonH , EliasA , ChaleJJ , CadeneA , GabrielS . Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low‐molecular‐weight heparin: the Vascular Midi‐Pyrenees study. Archives of Internal Medicine2000;160(12):1769‐73. ">Boccalon 2000</a> had a high rate of attrition, and we rated them as high risk. </p> </section> <section id="CD003076-sec-0061"> <h4 class="title">Selective reporting</h4> <p>We assessed a study for risk of selective outcome reporting according to the following.</p> <p> <ul id="CD003076-list-0007"> <li> <p>The published report included all expected outcomes.</p> </li> <li> <p>Outcomes were reported systematically for all comparison groups, based on prospectively collected data. </p> </li> </ul> </p> <p>We deemed risk of bias to be low if both of these criteria were met, unclear if these criteria were not met, and high if evidence indicated that data had been collected on outcomes of interest but were not reported in the study publication. </p> <p>We did not find any indication suggesting that outcomes were selectively reported in the included studies, so we rated all studies as low risk. </p> </section> <section id="CD003076-sec-0062"> <h4 class="title">Other potential sources of bias</h4> <p>We had no concerns regarding other potential sources of bias for two studies (<a href="./references#CD003076-bbs2-0002" title="BoccalonH , EliasA , ChaleJJ , CadeneA , DumoulinA . Treatment of deep vein thrombosis at home: from theory to medical practice [French]. Bulletin de l'Academie Nationale de Medecine1998;182(1):101‐15. BoccalonH , EliasA , ChaleJJ , CadeneA , GabrielS . Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low‐molecular‐weight heparin: the Vascular Midi‐Pyrenees study. Archives of Internal Medicine2000;160(12):1769‐73. ">Boccalon 2000</a>; <a href="./references#CD003076-bbs2-0004" title="DaskalopoulosME , DaskalopoulouSS , TzortzisE , SfiridisP , NikolaouA , DimitroulisD , et al. Long‐term treatment of deep venous thrombosis with a low molecular weight heparin (tinzaparin): a prospective randomized trial. European Journal of Vascular and Endovascular Surgery2005;29(6):638‐50. ">Daskalopoulos 2005</a>). For <a href="./references#CD003076-bbs2-0001" title="BäckmanK , CarlssonP , KentsonM , HansenS , EngquistL , HallertC . Deep venous thrombosis: a new task for primary health care. Scandinavian Journal of Primary Health Care2004;22(1):44‐9. ">Bäckman 2004</a>, <a href="./references#CD003076-bbs2-0003" title="ChongBH . A randomized, prospective, multicentre study comparing the efficacy, safety and cost of once‐daily enoxaparin given at home with unfractionated heparin given in hospital in the treatment of deep‐vein thrombosis. Blood2002;100(11):Abstract 2772. ChongBH , BrightonTA , BakerRI , ThurlowP , LeeCH , ASTH DS Group. Once‐daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep‐vein thrombosis. Journal of Thrombosis and Thrombolysis2005;19(3):173‐81. ">Chong 2005</a>, <a href="./references#CD003076-bbs2-0005" title="KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of patients with venous thrombosis with intravenous unfractionated heparin in hospital compared with subcutaneous low‐molecular‐weight heparin out of hospital. Annals of Hematology1996;72:A3. KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of venous thrombosis with intravenous unfractionated heparin in hospital as compared with subcutaneous low molecular weight heparin at home. New England Journal of Medicine1996;334(11):682‐7. van denBeltAGM , BossuytPMM , PrinsMH , GallusAS , BullerHR . Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis ‐ an economic evaluation. Thrombosis and Haemostasis1998;79:259‐62. ">Koopman 1996</a>, <a href="./references#CD003076-bbs2-0006" title="LevineM , GentM , HirschJ , LeclercJ , AndersonD , WeitzJ , et al. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis. New England Journal of Medicine1996;334:677‐82. O'BrienB , LevineM , WillanA , GoereeR , HaleyS , BlackhouseG , et al. Economic evaluation of outpatient treatment with low‐molecular‐weight‐heparin for proximal vein thrombosis. Archives of Internal Medicine1999;159:2298‐304. ">Levine 1996</a>, and <a href="./references#CD003076-bbs2-0007" title="RamacciottiE , AraujoGR , LastoriaS , DietrichF , MaffeiFH , MussiNS . The efficacy and safety of enoxaparin once‐daily given partly at home, compared with unfractionated heparin given in the hospital in the treatment of proximal deep‐vein thrombosis, a Brazilian multicenter study. Blood2001;98(11):Abstract 4026. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , DietrichF . An open‐label, comparative study of the efficacy and safety of an outpatient single daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Blood2002;11:503a‐Abstract 1960. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , Dietrich‐NetoF , CLETRAT Investigators. Efficacy and safety of once‐daily enoxaparin given in the outpatient setting compared with in‐hospital unfractionated heparin for treatment of proximal lower limb deep‐vein thrombosis. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1401. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , KaraoglanDM , MichaelisW , et al. An open‐label, comparative study of the efficacy and safety of once‐daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Thrombosis Research2004;114(3):149‐53. ">Ramacciotti 2004</a>, information was insufficient for review authors to judge whether there was potential for other bias; we rated these as having unclear risk, as each study included a large number of participants in the LMWH/home treatment group who were treated in hospital. <a href="./references#CD003076-bbs2-0005" title="KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of patients with venous thrombosis with intravenous unfractionated heparin in hospital compared with subcutaneous low‐molecular‐weight heparin out of hospital. Annals of Hematology1996;72:A3. KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of venous thrombosis with intravenous unfractionated heparin in hospital as compared with subcutaneous low molecular weight heparin at home. New England Journal of Medicine1996;334(11):682‐7. van denBeltAGM , BossuytPMM , PrinsMH , GallusAS , BullerHR . Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis ‐ an economic evaluation. Thrombosis and Haemostasis1998;79:259‐62. ">Koopman 1996</a>, <a href="./references#CD003076-bbs2-0006" title="LevineM , GentM , HirschJ , LeclercJ , AndersonD , WeitzJ , et al. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis. New England Journal of Medicine1996;334:677‐82. O'BrienB , LevineM , WillanA , GoereeR , HaleyS , BlackhouseG , et al. Economic evaluation of outpatient treatment with low‐molecular‐weight‐heparin for proximal vein thrombosis. Archives of Internal Medicine1999;159:2298‐304. ">Levine 1996</a>, and <a href="./references#CD003076-bbs2-0007" title="RamacciottiE , AraujoGR , LastoriaS , DietrichF , MaffeiFH , MussiNS . The efficacy and safety of enoxaparin once‐daily given partly at home, compared with unfractionated heparin given in the hospital in the treatment of proximal deep‐vein thrombosis, a Brazilian multicenter study. Blood2001;98(11):Abstract 4026. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , DietrichF . An open‐label, comparative study of the efficacy and safety of an outpatient single daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Blood2002;11:503a‐Abstract 1960. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , Dietrich‐NetoF , CLETRAT Investigators. Efficacy and safety of once‐daily enoxaparin given in the outpatient setting compared with in‐hospital unfractionated heparin for treatment of proximal lower limb deep‐vein thrombosis. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1401. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , KaraoglanDM , MichaelisW , et al. An open‐label, comparative study of the efficacy and safety of once‐daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Thrombosis Research2004;114(3):149‐53. ">Ramacciotti 2004</a> differed methodologically, as participants randomised to LMWH were treated only at home, as determined by a clinician, but were not specifically assigned to home treatment. We evaluated these studies by performing sensitivity analysis to assess their impact on evidence obtained through meta‐analysis. We have discussed these issues further in the section <a href="#CD003076-sec-0074">Overall completeness and applicability of evidence</a>. </p> </section> </section> <section id="CD003076-sec-0063"> <h3 class="title" id="CD003076-sec-0063">Effects of interventions</h3> <p>See: <a href="./full#CD003076-tbl-0001"><b>Summary of findings for the main comparison</b> Treatment of DVT at home compared with treatment in hospital</a> </p> <p>We have presented a summary of the findings of this review in <a href="./full#CD003076-tbl-0001">summary of findings Table for the main comparison</a>, and a summary of outcomes of included trials in <a href="#CD003076-tbl-0002">Table 1</a>. </p> <div class="table" id="CD003076-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of outcomes</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Setting</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of participants entered</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Heparin type</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean hospital stay (days)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Recurrence of VTE (%)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Major bleeding (%)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Minor bleeding (%)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Death (%)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean total direct costs per participant</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0001" title="BäckmanK , CarlssonP , KentsonM , HansenS , EngquistL , HallertC . Deep venous thrombosis: a new task for primary health care. Scandinavian Journal of Primary Health Care2004;22(1):44‐9. ">Bäckman 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hospital</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>LMWH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>SEK 16,400</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Home</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>LMWH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>SEK 12,100</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0002" title="BoccalonH , EliasA , ChaleJJ , CadeneA , DumoulinA . Treatment of deep vein thrombosis at home: from theory to medical practice [French]. Bulletin de l'Academie Nationale de Medecine1998;182(1):101‐15. BoccalonH , EliasA , ChaleJJ , CadeneA , GabrielS . Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low‐molecular‐weight heparin: the Vascular Midi‐Pyrenees study. Archives of Internal Medicine2000;160(12):1769‐73. ">Boccalon 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hospital</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>LMWH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fr 20,932</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Home</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>LMWH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fr 9230</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0003" title="ChongBH . A randomized, prospective, multicentre study comparing the efficacy, safety and cost of once‐daily enoxaparin given at home with unfractionated heparin given in hospital in the treatment of deep‐vein thrombosis. Blood2002;100(11):Abstract 2772. ChongBH , BrightonTA , BakerRI , ThurlowP , LeeCH , ASTH DS Group. Once‐daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep‐vein thrombosis. Journal of Thrombosis and Thrombolysis2005;19(3):173‐81. ">Chong 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hospital</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UFH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Home</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>LMWH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0004" title="DaskalopoulosME , DaskalopoulouSS , TzortzisE , SfiridisP , NikolaouA , DimitroulisD , et al. Long‐term treatment of deep venous thrombosis with a low molecular weight heparin (tinzaparin): a prospective randomized trial. European Journal of Vascular and Endovascular Surgery2005;29(6):638‐50. ">Daskalopoulos 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hospital</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UFH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Home</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>LMWH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0005" title="KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of patients with venous thrombosis with intravenous unfractionated heparin in hospital compared with subcutaneous low‐molecular‐weight heparin out of hospital. Annals of Hematology1996;72:A3. KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of venous thrombosis with intravenous unfractionated heparin in hospital as compared with subcutaneous low molecular weight heparin at home. New England Journal of Medicine1996;334(11):682‐7. van denBeltAGM , BossuytPMM , PrinsMH , GallusAS , BullerHR . Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis ‐ an economic evaluation. Thrombosis and Haemostasis1998;79:259‐62. ">Koopman 1996</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hospital</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UFH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Home</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>202</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>LMWH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0006" title="LevineM , GentM , HirschJ , LeclercJ , AndersonD , WeitzJ , et al. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis. New England Journal of Medicine1996;334:677‐82. O'BrienB , LevineM , WillanA , GoereeR , HaleyS , BlackhouseG , et al. Economic evaluation of outpatient treatment with low‐molecular‐weight‐heparin for proximal vein thrombosis. Archives of Internal Medicine1999;159:2298‐304. ">Levine 1996</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hospital</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UFH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Home</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>247</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>LMWH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0007" title="RamacciottiE , AraujoGR , LastoriaS , DietrichF , MaffeiFH , MussiNS . The efficacy and safety of enoxaparin once‐daily given partly at home, compared with unfractionated heparin given in the hospital in the treatment of proximal deep‐vein thrombosis, a Brazilian multicenter study. Blood2001;98(11):Abstract 4026. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , DietrichF . An open‐label, comparative study of the efficacy and safety of an outpatient single daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Blood2002;11:503a‐Abstract 1960. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , Dietrich‐NetoF , CLETRAT Investigators. Efficacy and safety of once‐daily enoxaparin given in the outpatient setting compared with in‐hospital unfractionated heparin for treatment of proximal lower limb deep‐vein thrombosis. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1401. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , KaraoglanDM , MichaelisW , et al. An open‐label, comparative study of the efficacy and safety of once‐daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Thrombosis Research2004;114(3):149‐53. ">Ramacciotti 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hospital</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>LMWH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Home</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UFH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>LMWH: low molecular weight heparin.<br/> UFH: unfractionated heparin.<br/> VTE: venous thromboembolism. </p> </div> </div> <section id="CD003076-sec-0064"> <h4 class="title">Recurrent VTE (PE or recurrence of DVT)</h4> <p>Six studies reported on this outcome (<a href="./references#CD003076-bbs2-0002" title="BoccalonH , EliasA , ChaleJJ , CadeneA , DumoulinA . Treatment of deep vein thrombosis at home: from theory to medical practice [French]. Bulletin de l'Academie Nationale de Medecine1998;182(1):101‐15. BoccalonH , EliasA , ChaleJJ , CadeneA , GabrielS . Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low‐molecular‐weight heparin: the Vascular Midi‐Pyrenees study. Archives of Internal Medicine2000;160(12):1769‐73. ">Boccalon 2000</a>; <a href="./references#CD003076-bbs2-0003" title="ChongBH . A randomized, prospective, multicentre study comparing the efficacy, safety and cost of once‐daily enoxaparin given at home with unfractionated heparin given in hospital in the treatment of deep‐vein thrombosis. Blood2002;100(11):Abstract 2772. ChongBH , BrightonTA , BakerRI , ThurlowP , LeeCH , ASTH DS Group. Once‐daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep‐vein thrombosis. Journal of Thrombosis and Thrombolysis2005;19(3):173‐81. ">Chong 2005</a>; <a href="./references#CD003076-bbs2-0004" title="DaskalopoulosME , DaskalopoulouSS , TzortzisE , SfiridisP , NikolaouA , DimitroulisD , et al. Long‐term treatment of deep venous thrombosis with a low molecular weight heparin (tinzaparin): a prospective randomized trial. European Journal of Vascular and Endovascular Surgery2005;29(6):638‐50. ">Daskalopoulos 2005</a>; <a href="./references#CD003076-bbs2-0005" title="KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of patients with venous thrombosis with intravenous unfractionated heparin in hospital compared with subcutaneous low‐molecular‐weight heparin out of hospital. Annals of Hematology1996;72:A3. KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of venous thrombosis with intravenous unfractionated heparin in hospital as compared with subcutaneous low molecular weight heparin at home. New England Journal of Medicine1996;334(11):682‐7. van denBeltAGM , BossuytPMM , PrinsMH , GallusAS , BullerHR . Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis ‐ an economic evaluation. Thrombosis and Haemostasis1998;79:259‐62. ">Koopman 1996</a>; <a href="./references#CD003076-bbs2-0006" title="LevineM , GentM , HirschJ , LeclercJ , AndersonD , WeitzJ , et al. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis. New England Journal of Medicine1996;334:677‐82. O'BrienB , LevineM , WillanA , GoereeR , HaleyS , BlackhouseG , et al. Economic evaluation of outpatient treatment with low‐molecular‐weight‐heparin for proximal vein thrombosis. Archives of Internal Medicine1999;159:2298‐304. ">Levine 1996</a>; <a href="./references#CD003076-bbs2-0007" title="RamacciottiE , AraujoGR , LastoriaS , DietrichF , MaffeiFH , MussiNS . The efficacy and safety of enoxaparin once‐daily given partly at home, compared with unfractionated heparin given in the hospital in the treatment of proximal deep‐vein thrombosis, a Brazilian multicenter study. Blood2001;98(11):Abstract 4026. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , DietrichF . An open‐label, comparative study of the efficacy and safety of an outpatient single daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Blood2002;11:503a‐Abstract 1960. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , Dietrich‐NetoF , CLETRAT Investigators. Efficacy and safety of once‐daily enoxaparin given in the outpatient setting compared with in‐hospital unfractionated heparin for treatment of proximal lower limb deep‐vein thrombosis. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1401. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , KaraoglanDM , MichaelisW , et al. An open‐label, comparative study of the efficacy and safety of once‐daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Thrombosis Research2004;114(3):149‐53. ">Ramacciotti 2004</a>). Outcome follow‐up time ranged from three months to one year. Pooled results showed differences in recurrence of VTE between home and hospital treatment, with home treatment carrying less risk of recurrent VTE (RR 0.58, 95% CI 0.39 to 0.86; 1708 participants; 6 studies; I² = 0%; P = 0.007; <a href="./references#CD003076-fig-0004" title="">Analysis 1.1</a>). We rated the evidence as low quality owing to risk of bias and indirectness concerns. </p> </section> <section id="CD003076-sec-0065"> <h4 class="title">Venous gangrene</h4> <p>Included studies reported no cases of venous gangrene.</p> </section> <section id="CD003076-sec-0066"> <h4 class="title">Heparin complications including major and minor bleeding</h4> <p>Six studies reported on this outcome (<a href="./references#CD003076-bbs2-0002" title="BoccalonH , EliasA , ChaleJJ , CadeneA , DumoulinA . Treatment of deep vein thrombosis at home: from theory to medical practice [French]. Bulletin de l'Academie Nationale de Medecine1998;182(1):101‐15. BoccalonH , EliasA , ChaleJJ , CadeneA , GabrielS . Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low‐molecular‐weight heparin: the Vascular Midi‐Pyrenees study. Archives of Internal Medicine2000;160(12):1769‐73. ">Boccalon 2000</a>; <a href="./references#CD003076-bbs2-0003" title="ChongBH . A randomized, prospective, multicentre study comparing the efficacy, safety and cost of once‐daily enoxaparin given at home with unfractionated heparin given in hospital in the treatment of deep‐vein thrombosis. Blood2002;100(11):Abstract 2772. ChongBH , BrightonTA , BakerRI , ThurlowP , LeeCH , ASTH DS Group. Once‐daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep‐vein thrombosis. Journal of Thrombosis and Thrombolysis2005;19(3):173‐81. ">Chong 2005</a>; <a href="./references#CD003076-bbs2-0004" title="DaskalopoulosME , DaskalopoulouSS , TzortzisE , SfiridisP , NikolaouA , DimitroulisD , et al. Long‐term treatment of deep venous thrombosis with a low molecular weight heparin (tinzaparin): a prospective randomized trial. European Journal of Vascular and Endovascular Surgery2005;29(6):638‐50. ">Daskalopoulos 2005</a>; <a href="./references#CD003076-bbs2-0005" title="KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of patients with venous thrombosis with intravenous unfractionated heparin in hospital compared with subcutaneous low‐molecular‐weight heparin out of hospital. Annals of Hematology1996;72:A3. KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of venous thrombosis with intravenous unfractionated heparin in hospital as compared with subcutaneous low molecular weight heparin at home. New England Journal of Medicine1996;334(11):682‐7. van denBeltAGM , BossuytPMM , PrinsMH , GallusAS , BullerHR . Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis ‐ an economic evaluation. Thrombosis and Haemostasis1998;79:259‐62. ">Koopman 1996</a>; <a href="./references#CD003076-bbs2-0006" title="LevineM , GentM , HirschJ , LeclercJ , AndersonD , WeitzJ , et al. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis. New England Journal of Medicine1996;334:677‐82. O'BrienB , LevineM , WillanA , GoereeR , HaleyS , BlackhouseG , et al. Economic evaluation of outpatient treatment with low‐molecular‐weight‐heparin for proximal vein thrombosis. Archives of Internal Medicine1999;159:2298‐304. ">Levine 1996</a>; <a href="./references#CD003076-bbs2-0007" title="RamacciottiE , AraujoGR , LastoriaS , DietrichF , MaffeiFH , MussiNS . The efficacy and safety of enoxaparin once‐daily given partly at home, compared with unfractionated heparin given in the hospital in the treatment of proximal deep‐vein thrombosis, a Brazilian multicenter study. Blood2001;98(11):Abstract 4026. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , DietrichF . An open‐label, comparative study of the efficacy and safety of an outpatient single daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Blood2002;11:503a‐Abstract 1960. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , Dietrich‐NetoF , CLETRAT Investigators. Efficacy and safety of once‐daily enoxaparin given in the outpatient setting compared with in‐hospital unfractionated heparin for treatment of proximal lower limb deep‐vein thrombosis. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1401. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , KaraoglanDM , MichaelisW , et al. An open‐label, comparative study of the efficacy and safety of once‐daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Thrombosis Research2004;114(3):149‐53. ">Ramacciotti 2004</a>). Outcome follow‐up ranged from 14 days to one year. </p> <p>Pooling of results on major bleeding revealed no clear differences between home and hospital treatment groups (RR 0.67, 95% CI 0.33 to 1.36; 1708 participants; 6 studies; I² = 0%; P = 0.27; <a href="./references#CD003076-fig-0005" title="">Analysis 1.2</a>). We rated the evidence as low quality owing to risk of bias and indirectness concerns. </p> <p>For the outcome of minor bleeding, data show no clear differences between hospital and home treatment arms (RR 1.29, 95% CI 0.94 to 1.78; 1708 participants; 6 studies; I² = 0%; P = 0.11; <a href="./references#CD003076-fig-0006" title="">Analysis 1.3</a>). We rated the evidence as low quality owing to risk of bias and indirectness concerns. </p> </section> <section id="CD003076-sec-0067"> <h4 class="title">Death</h4> <p>Six studies included reports on death, with follow‐up ranging from three months to one year (<a href="./references#CD003076-bbs2-0002" title="BoccalonH , EliasA , ChaleJJ , CadeneA , DumoulinA . Treatment of deep vein thrombosis at home: from theory to medical practice [French]. Bulletin de l'Academie Nationale de Medecine1998;182(1):101‐15. BoccalonH , EliasA , ChaleJJ , CadeneA , GabrielS . Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low‐molecular‐weight heparin: the Vascular Midi‐Pyrenees study. Archives of Internal Medicine2000;160(12):1769‐73. ">Boccalon 2000</a>; <a href="./references#CD003076-bbs2-0003" title="ChongBH . A randomized, prospective, multicentre study comparing the efficacy, safety and cost of once‐daily enoxaparin given at home with unfractionated heparin given in hospital in the treatment of deep‐vein thrombosis. Blood2002;100(11):Abstract 2772. ChongBH , BrightonTA , BakerRI , ThurlowP , LeeCH , ASTH DS Group. Once‐daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep‐vein thrombosis. Journal of Thrombosis and Thrombolysis2005;19(3):173‐81. ">Chong 2005</a>; <a href="./references#CD003076-bbs2-0004" title="DaskalopoulosME , DaskalopoulouSS , TzortzisE , SfiridisP , NikolaouA , DimitroulisD , et al. Long‐term treatment of deep venous thrombosis with a low molecular weight heparin (tinzaparin): a prospective randomized trial. European Journal of Vascular and Endovascular Surgery2005;29(6):638‐50. ">Daskalopoulos 2005</a>; <a href="./references#CD003076-bbs2-0005" title="KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of patients with venous thrombosis with intravenous unfractionated heparin in hospital compared with subcutaneous low‐molecular‐weight heparin out of hospital. Annals of Hematology1996;72:A3. KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of venous thrombosis with intravenous unfractionated heparin in hospital as compared with subcutaneous low molecular weight heparin at home. New England Journal of Medicine1996;334(11):682‐7. van denBeltAGM , BossuytPMM , PrinsMH , GallusAS , BullerHR . Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis ‐ an economic evaluation. Thrombosis and Haemostasis1998;79:259‐62. ">Koopman 1996</a>; <a href="./references#CD003076-bbs2-0006" title="LevineM , GentM , HirschJ , LeclercJ , AndersonD , WeitzJ , et al. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis. New England Journal of Medicine1996;334:677‐82. O'BrienB , LevineM , WillanA , GoereeR , HaleyS , BlackhouseG , et al. Economic evaluation of outpatient treatment with low‐molecular‐weight‐heparin for proximal vein thrombosis. Archives of Internal Medicine1999;159:2298‐304. ">Levine 1996</a>; <a href="./references#CD003076-bbs2-0007" title="RamacciottiE , AraujoGR , LastoriaS , DietrichF , MaffeiFH , MussiNS . The efficacy and safety of enoxaparin once‐daily given partly at home, compared with unfractionated heparin given in the hospital in the treatment of proximal deep‐vein thrombosis, a Brazilian multicenter study. Blood2001;98(11):Abstract 4026. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , DietrichF . An open‐label, comparative study of the efficacy and safety of an outpatient single daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Blood2002;11:503a‐Abstract 1960. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , Dietrich‐NetoF , CLETRAT Investigators. Efficacy and safety of once‐daily enoxaparin given in the outpatient setting compared with in‐hospital unfractionated heparin for treatment of proximal lower limb deep‐vein thrombosis. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1401. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , KaraoglanDM , MichaelisW , et al. An open‐label, comparative study of the efficacy and safety of once‐daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Thrombosis Research2004;114(3):149‐53. ">Ramacciotti 2004</a>). Meta‐analysis of trial results showed no clear differences in numbers of deaths between home‐ and hospital‐treated groups (RR 0.69, 95% CI 0.44 to 1.09; 1708 participants; 6 studies; I² = 0%; P = 0.11; <a href="./references#CD003076-fig-0007" title="">Analysis 1.4</a>). We rated the evidence as low quality owing to risk of bias and indirectness concerns. </p> </section> <section id="CD003076-sec-0068"> <h4 class="title">Patient satisfaction and quality of life</h4> <p>Three studies included data on quality of life (QoL) (<a href="./references#CD003076-bbs2-0001" title="BäckmanK , CarlssonP , KentsonM , HansenS , EngquistL , HallertC . Deep venous thrombosis: a new task for primary health care. Scandinavian Journal of Primary Health Care2004;22(1):44‐9. ">Bäckman 2004</a>; <a href="./references#CD003076-bbs2-0005" title="KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of patients with venous thrombosis with intravenous unfractionated heparin in hospital compared with subcutaneous low‐molecular‐weight heparin out of hospital. Annals of Hematology1996;72:A3. KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of venous thrombosis with intravenous unfractionated heparin in hospital as compared with subcutaneous low molecular weight heparin at home. New England Journal of Medicine1996;334(11):682‐7. van denBeltAGM , BossuytPMM , PrinsMH , GallusAS , BullerHR . Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis ‐ an economic evaluation. Thrombosis and Haemostasis1998;79:259‐62. ">Koopman 1996</a>; <a href="./references#CD003076-bbs2-0006" title="LevineM , GentM , HirschJ , LeclercJ , AndersonD , WeitzJ , et al. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis. New England Journal of Medicine1996;334:677‐82. O'BrienB , LevineM , WillanA , GoereeR , HaleyS , BlackhouseG , et al. Economic evaluation of outpatient treatment with low‐molecular‐weight‐heparin for proximal vein thrombosis. Archives of Internal Medicine1999;159:2298‐304. ">Levine 1996</a>). <a href="./references#CD003076-bbs2-0001" title="BäckmanK , CarlssonP , KentsonM , HansenS , EngquistL , HallertC . Deep venous thrombosis: a new task for primary health care. Scandinavian Journal of Primary Health Care2004;22(1):44‐9. ">Bäckman 2004</a> assessed QoL using the EuroQoL tool based on five dimensions (EQ‐5D) and found no differences between treatment groups in mean QoL scores, nor in the proportion of participants showing improvement in self‐rated health state. QoL was assessed immediately after treatment and after three months. A substantial number of participants randomised to in‐patient care in this study chose out‐patient treatment, predominantly as a personal/social preference. The <a href="./references#CD003076-bbs2-0005" title="KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of patients with venous thrombosis with intravenous unfractionated heparin in hospital compared with subcutaneous low‐molecular‐weight heparin out of hospital. Annals of Hematology1996;72:A3. KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of venous thrombosis with intravenous unfractionated heparin in hospital as compared with subcutaneous low molecular weight heparin at home. New England Journal of Medicine1996;334(11):682‐7. van denBeltAGM , BossuytPMM , PrinsMH , GallusAS , BullerHR . Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis ‐ an economic evaluation. Thrombosis and Haemostasis1998;79:259‐62. ">Koopman 1996</a> trial measured QoL by using the Medical Outcome Study Short Form 20 as a generic measure of physical and mental health, as well as an adapted version of the Rotterdam Symptom Checklist, which is specific to thrombosis; measurements were taken at baseline, at end of treatment course, and at 12 weeks and 24 weeks after treatment. At 24 weeks after treatment, over 80% of both trial groups had completed the QoL questionnaires. Overall, participants in both groups showed improvement in QoL; two out of six criteria (physical activity and social functioning) showed an advantage for those in the LMWH group at completion of initial treatment, but this difference was not seen at 12 weeks or at 24 weeks after treatment. <a href="./references#CD003076-bbs2-0006" title="LevineM , GentM , HirschJ , LeclercJ , AndersonD , WeitzJ , et al. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis. New England Journal of Medicine1996;334:677‐82. O'BrienB , LevineM , WillanA , GoereeR , HaleyS , BlackhouseG , et al. Economic evaluation of outpatient treatment with low‐molecular‐weight‐heparin for proximal vein thrombosis. Archives of Internal Medicine1999;159:2298‐304. ">Levine 1996</a> reported on QoL seven days after treatment using the Medical Outcomes Study Short Form 36, which reports on eight physical and mental health domains. Only the social functioning domain showed greater improvement among participants treated at home compared with those given heparin treatment; data show no differences between the two treatment groups in terms of the other domains (<a href="./references#CD003076-bbs2-0049" title="O'BrienB , LevineM , WillanA , GoereeR , HaleyS , BlackhouseG , et al. Economic evaluation of outpatient treatment with low‐molecular‐weight‐heparin for proximal vein thrombosis. Archives of Internal Medicine1999;159:2298‐304. ">O'Brien 1999</a>). We could not carry out meta‐analysis for this outcome owing to heterogeneity in reporting of QoL and the paucity of data reported by trial authors. </p> <p>We rated the quality of evidence for this outcome as very low owing to risk of bias, indirectness, and heterogeneity of measurement and reporting. </p> </section> <section id="CD003076-sec-0069"> <h4 class="title">Cost‐effectiveness of treatment</h4> <p><a href="./references#CD003076-bbs2-0001" title="BäckmanK , CarlssonP , KentsonM , HansenS , EngquistL , HallertC . Deep venous thrombosis: a new task for primary health care. Scandinavian Journal of Primary Health Care2004;22(1):44‐9. ">Bäckman 2004</a>, <a href="./references#CD003076-bbs2-0002" title="BoccalonH , EliasA , ChaleJJ , CadeneA , DumoulinA . Treatment of deep vein thrombosis at home: from theory to medical practice [French]. Bulletin de l'Academie Nationale de Medecine1998;182(1):101‐15. BoccalonH , EliasA , ChaleJJ , CadeneA , GabrielS . Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low‐molecular‐weight heparin: the Vascular Midi‐Pyrenees study. Archives of Internal Medicine2000;160(12):1769‐73. ">Boccalon 2000</a>, <a href="./references#CD003076-bbs2-0004" title="DaskalopoulosME , DaskalopoulouSS , TzortzisE , SfiridisP , NikolaouA , DimitroulisD , et al. Long‐term treatment of deep venous thrombosis with a low molecular weight heparin (tinzaparin): a prospective randomized trial. European Journal of Vascular and Endovascular Surgery2005;29(6):638‐50. ">Daskalopoulos 2005</a>, and <a href="./references#CD003076-bbs2-0005" title="KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of patients with venous thrombosis with intravenous unfractionated heparin in hospital compared with subcutaneous low‐molecular‐weight heparin out of hospital. Annals of Hematology1996;72:A3. KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of venous thrombosis with intravenous unfractionated heparin in hospital as compared with subcutaneous low molecular weight heparin at home. New England Journal of Medicine1996;334(11):682‐7. van denBeltAGM , BossuytPMM , PrinsMH , GallusAS , BullerHR . Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis ‐ an economic evaluation. Thrombosis and Haemostasis1998;79:259‐62. ">Koopman 1996</a> all reported on cost‐effectiveness of compared treatments, but because of the way investigators presented data, we could perform no meta‐analysis for this outcome. </p> <p>In <a href="./references#CD003076-bbs2-0001" title="BäckmanK , CarlssonP , KentsonM , HansenS , EngquistL , HallertC . Deep venous thrombosis: a new task for primary health care. Scandinavian Journal of Primary Health Care2004;22(1):44‐9. ">Bäckman 2004</a>, which reported on costs within three months of treatment, 224 participants were eligible, 131 entered the trial, and 124 completed the economic portion of the study. Total direct costs were higher for participants in the in‐patient strategy group(i.e. Swedish Crown (SEK) 16,400 per participant (Euro (EUR) 1899) compared with SEK 12,100 per participant (EUR 1405)) than for those in the out‐patient (home) strategy group (P &lt; 0.0010). </p> <p><a href="./references#CD003076-bbs2-0005" title="KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of patients with venous thrombosis with intravenous unfractionated heparin in hospital compared with subcutaneous low‐molecular‐weight heparin out of hospital. Annals of Hematology1996;72:A3. KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of venous thrombosis with intravenous unfractionated heparin in hospital as compared with subcutaneous low molecular weight heparin at home. New England Journal of Medicine1996;334(11):682‐7. van denBeltAGM , BossuytPMM , PrinsMH , GallusAS , BullerHR . Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis ‐ an economic evaluation. Thrombosis and Haemostasis1998;79:259‐62. ">Koopman 1996</a> followed participants for six months and used trial results to compare cost of treatment calculations between the two arms of the trial (<a href="./references#CD003076-bbs2-0054" title="van denBeltAGM , BossuytPMM , PrinsMH , GallusAS , BullerHR . Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis ‐ an economic evaluation. Thrombosis and Haemostasis1998;79:259‐62. ">van den Belt 1998</a>). Data show a 64% savings among those treated with LMWH as opposed to UFH, largely owing to lower hospital costs. Trialists stated that this was a conservative estimate of the potential reduction in costs. Similarly, an evaluation of participants entered into the <a href="./references#CD003076-bbs2-0006" title="LevineM , GentM , HirschJ , LeclercJ , AndersonD , WeitzJ , et al. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis. New England Journal of Medicine1996;334:677‐82. O'BrienB , LevineM , WillanA , GoereeR , HaleyS , BlackhouseG , et al. Economic evaluation of outpatient treatment with low‐molecular‐weight‐heparin for proximal vein thrombosis. Archives of Internal Medicine1999;159:2298‐304. ">Levine 1996</a> trial showed cost savings of 57% (<a href="./references#CD003076-bbs2-0049" title="O'BrienB , LevineM , WillanA , GoereeR , HaleyS , BlackhouseG , et al. Economic evaluation of outpatient treatment with low‐molecular‐weight‐heparin for proximal vein thrombosis. Archives of Internal Medicine1999;159:2298‐304. ">O'Brien 1999</a>); researchers followed participants for three months. This latter figure is confirmed by <a href="./references#CD003076-bbs2-0002" title="BoccalonH , EliasA , ChaleJJ , CadeneA , DumoulinA . Treatment of deep vein thrombosis at home: from theory to medical practice [French]. Bulletin de l'Academie Nationale de Medecine1998;182(1):101‐15. BoccalonH , EliasA , ChaleJJ , CadeneA , GabrielS . Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low‐molecular‐weight heparin: the Vascular Midi‐Pyrenees study. Archives of Internal Medicine2000;160(12):1769‐73. ">Boccalon 2000</a>, which showed that the mean cost of in‐patient treatment over 10 days was over 55% higher than the mean cost of out‐patient treatment over the same time period. Similarly, in <a href="./references#CD003076-bbs2-0004" title="DaskalopoulosME , DaskalopoulouSS , TzortzisE , SfiridisP , NikolaouA , DimitroulisD , et al. Long‐term treatment of deep venous thrombosis with a low molecular weight heparin (tinzaparin): a prospective randomized trial. European Journal of Vascular and Endovascular Surgery2005;29(6):638‐50. ">Daskalopoulos 2005</a>, which reported on 12 months of follow‐up, estimated costs slightly favoured the LMWH group because of the significant cut in hospitalisation. </p> <p>We rated the quality of evidence for this outcome as very low owing to risk of bias, indirectness, and heterogeneity of measurement and reporting. </p> </section> <section id="CD003076-sec-0070"> <h4 class="title">Other outcomes of interest</h4> <p>None of the included trials considered the incidence of post‐thrombotic syndrome.</p> <p>Mean hospital stay for participants without events such as bleeding or (suspected) recurrences in <a href="./references#CD003076-bbs2-0005" title="KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of patients with venous thrombosis with intravenous unfractionated heparin in hospital compared with subcutaneous low‐molecular‐weight heparin out of hospital. Annals of Hematology1996;72:A3. KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of venous thrombosis with intravenous unfractionated heparin in hospital as compared with subcutaneous low molecular weight heparin at home. New England Journal of Medicine1996;334(11):682‐7. van denBeltAGM , BossuytPMM , PrinsMH , GallusAS , BullerHR . Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis ‐ an economic evaluation. Thrombosis and Haemostasis1998;79:259‐62. ">Koopman 1996</a> was 8.1 days for the hospital‐treated 'control' group, and 2.7 days for the home‐treated 'treatment' group. In the other large trial (<a href="./references#CD003076-bbs2-0006" title="LevineM , GentM , HirschJ , LeclercJ , AndersonD , WeitzJ , et al. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis. New England Journal of Medicine1996;334:677‐82. O'BrienB , LevineM , WillanA , GoereeR , HaleyS , BlackhouseG , et al. Economic evaluation of outpatient treatment with low‐molecular‐weight‐heparin for proximal vein thrombosis. Archives of Internal Medicine1999;159:2298‐304. ">Levine 1996</a>), mean hospital stay was 6.5 days for the hospital‐treated control group and 2.1 days for the home‐treated group. Mean hospital stay in <a href="./references#CD003076-bbs2-0002" title="BoccalonH , EliasA , ChaleJJ , CadeneA , DumoulinA . Treatment of deep vein thrombosis at home: from theory to medical practice [French]. Bulletin de l'Academie Nationale de Medecine1998;182(1):101‐15. BoccalonH , EliasA , ChaleJJ , CadeneA , GabrielS . Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low‐molecular‐weight heparin: the Vascular Midi‐Pyrenees study. Archives of Internal Medicine2000;160(12):1769‐73. ">Boccalon 2000</a> was 9.6 days for the hospital‐treated group and one day for the home‐treated group. <a href="./references#CD003076-bbs2-0007" title="RamacciottiE , AraujoGR , LastoriaS , DietrichF , MaffeiFH , MussiNS . The efficacy and safety of enoxaparin once‐daily given partly at home, compared with unfractionated heparin given in the hospital in the treatment of proximal deep‐vein thrombosis, a Brazilian multicenter study. Blood2001;98(11):Abstract 4026. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , DietrichF . An open‐label, comparative study of the efficacy and safety of an outpatient single daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Blood2002;11:503a‐Abstract 1960. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , Dietrich‐NetoF , CLETRAT Investigators. Efficacy and safety of once‐daily enoxaparin given in the outpatient setting compared with in‐hospital unfractionated heparin for treatment of proximal lower limb deep‐vein thrombosis. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1401. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , KaraoglanDM , MichaelisW , et al. An open‐label, comparative study of the efficacy and safety of once‐daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Thrombosis Research2004;114(3):149‐53. ">Ramacciotti 2004</a> reported a mean hospital stay of three days for home‐treated participants and seven days for hospital‐treated participants. Three studies did not report duration of hospital stay (<a href="./references#CD003076-bbs2-0001" title="BäckmanK , CarlssonP , KentsonM , HansenS , EngquistL , HallertC . Deep venous thrombosis: a new task for primary health care. Scandinavian Journal of Primary Health Care2004;22(1):44‐9. ">Bäckman 2004</a>; <a href="./references#CD003076-bbs2-0003" title="ChongBH . A randomized, prospective, multicentre study comparing the efficacy, safety and cost of once‐daily enoxaparin given at home with unfractionated heparin given in hospital in the treatment of deep‐vein thrombosis. Blood2002;100(11):Abstract 2772. ChongBH , BrightonTA , BakerRI , ThurlowP , LeeCH , ASTH DS Group. Once‐daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep‐vein thrombosis. Journal of Thrombosis and Thrombolysis2005;19(3):173‐81. ">Chong 2005</a>; <a href="./references#CD003076-bbs2-0004" title="DaskalopoulosME , DaskalopoulouSS , TzortzisE , SfiridisP , NikolaouA , DimitroulisD , et al. Long‐term treatment of deep venous thrombosis with a low molecular weight heparin (tinzaparin): a prospective randomized trial. European Journal of Vascular and Endovascular Surgery2005;29(6):638‐50. ">Daskalopoulos 2005</a>). </p> <p>Thirty‐six per cent of participants in <a href="./references#CD003076-bbs2-0005" title="KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of patients with venous thrombosis with intravenous unfractionated heparin in hospital compared with subcutaneous low‐molecular‐weight heparin out of hospital. Annals of Hematology1996;72:A3. KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of venous thrombosis with intravenous unfractionated heparin in hospital as compared with subcutaneous low molecular weight heparin at home. New England Journal of Medicine1996;334(11):682‐7. van denBeltAGM , BossuytPMM , PrinsMH , GallusAS , BullerHR . Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis ‐ an economic evaluation. Thrombosis and Haemostasis1998;79:259‐62. ">Koopman 1996</a> were treated entirely at home, 39% had a short hospital stay, and 25% were entirely hospital treated. Fifty per cent of participants in <a href="./references#CD003076-bbs2-0006" title="LevineM , GentM , HirschJ , LeclercJ , AndersonD , WeitzJ , et al. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis. New England Journal of Medicine1996;334:677‐82. O'BrienB , LevineM , WillanA , GoereeR , HaleyS , BlackhouseG , et al. Economic evaluation of outpatient treatment with low‐molecular‐weight‐heparin for proximal vein thrombosis. Archives of Internal Medicine1999;159:2298‐304. ">Levine 1996</a> were treated entirely at home. In <a href="./references#CD003076-bbs2-0004" title="DaskalopoulosME , DaskalopoulouSS , TzortzisE , SfiridisP , NikolaouA , DimitroulisD , et al. Long‐term treatment of deep venous thrombosis with a low molecular weight heparin (tinzaparin): a prospective randomized trial. European Journal of Vascular and Endovascular Surgery2005;29(6):638‐50. ">Daskalopoulos 2005</a>, no participant allocated to receive treatment with LMWH underwent any hospitalisation. </p> <p>Seventy‐seven per cent of participants in the home arm (LMWH group) of the <a href="./references#CD003076-bbs2-0003" title="ChongBH . A randomized, prospective, multicentre study comparing the efficacy, safety and cost of once‐daily enoxaparin given at home with unfractionated heparin given in hospital in the treatment of deep‐vein thrombosis. Blood2002;100(11):Abstract 2772. ChongBH , BrightonTA , BakerRI , ThurlowP , LeeCH , ASTH DS Group. Once‐daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep‐vein thrombosis. Journal of Thrombosis and Thrombolysis2005;19(3):173‐81. ">Chong 2005</a> trial were admitted to hospital. Twelve per cent were released on the day of admission, 34% were kept for one day, and 31% were kept for two or more nights. <a href="./references#CD003076-bbs2-0007" title="RamacciottiE , AraujoGR , LastoriaS , DietrichF , MaffeiFH , MussiNS . The efficacy and safety of enoxaparin once‐daily given partly at home, compared with unfractionated heparin given in the hospital in the treatment of proximal deep‐vein thrombosis, a Brazilian multicenter study. Blood2001;98(11):Abstract 4026. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , DietrichF . An open‐label, comparative study of the efficacy and safety of an outpatient single daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Blood2002;11:503a‐Abstract 1960. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , Dietrich‐NetoF , CLETRAT Investigators. Efficacy and safety of once‐daily enoxaparin given in the outpatient setting compared with in‐hospital unfractionated heparin for treatment of proximal lower limb deep‐vein thrombosis. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1401. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , KaraoglanDM , MichaelisW , et al. An open‐label, comparative study of the efficacy and safety of once‐daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Thrombosis Research2004;114(3):149‐53. ">Ramacciotti 2004</a> reported hospitalisation for all hospital‐treated participants and for 64% of home‐treated participants. </p> </section> <section id="CD003076-sec-0071"> <h4 class="title">Heterogeneity, subgroup analysis, and sensitivity analysis</h4> <p>We found heterogeneity in pooled effect estimates to be very low and had no reason to further investigate. When we performed sensitivity analysis, we found no difference in the effect when we removed studies at high risk of bias (<a href="./references#CD003076-bbs2-0007" title="RamacciottiE , AraujoGR , LastoriaS , DietrichF , MaffeiFH , MussiNS . The efficacy and safety of enoxaparin once‐daily given partly at home, compared with unfractionated heparin given in the hospital in the treatment of proximal deep‐vein thrombosis, a Brazilian multicenter study. Blood2001;98(11):Abstract 4026. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , DietrichF . An open‐label, comparative study of the efficacy and safety of an outpatient single daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Blood2002;11:503a‐Abstract 1960. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , Dietrich‐NetoF , CLETRAT Investigators. Efficacy and safety of once‐daily enoxaparin given in the outpatient setting compared with in‐hospital unfractionated heparin for treatment of proximal lower limb deep‐vein thrombosis. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1401. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , KaraoglanDM , MichaelisW , et al. An open‐label, comparative study of the efficacy and safety of once‐daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Thrombosis Research2004;114(3):149‐53. ">Ramacciotti 2004</a>). No analyses showed a majority weight by a single study, so we performed no sensitivity analyses on these criteria. We performed sensitivity analysis by evaluating the impact of the <a href="./references#CD003076-bbs2-0005" title="KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of patients with venous thrombosis with intravenous unfractionated heparin in hospital compared with subcutaneous low‐molecular‐weight heparin out of hospital. Annals of Hematology1996;72:A3. KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of venous thrombosis with intravenous unfractionated heparin in hospital as compared with subcutaneous low molecular weight heparin at home. New England Journal of Medicine1996;334(11):682‐7. van denBeltAGM , BossuytPMM , PrinsMH , GallusAS , BullerHR . Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis ‐ an economic evaluation. Thrombosis and Haemostasis1998;79:259‐62. ">Koopman 1996</a>, <a href="./references#CD003076-bbs2-0006" title="LevineM , GentM , HirschJ , LeclercJ , AndersonD , WeitzJ , et al. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis. New England Journal of Medicine1996;334:677‐82. O'BrienB , LevineM , WillanA , GoereeR , HaleyS , BlackhouseG , et al. Economic evaluation of outpatient treatment with low‐molecular‐weight‐heparin for proximal vein thrombosis. Archives of Internal Medicine1999;159:2298‐304. ">Levine 1996</a>, and <a href="./references#CD003076-bbs2-0007" title="RamacciottiE , AraujoGR , LastoriaS , DietrichF , MaffeiFH , MussiNS . The efficacy and safety of enoxaparin once‐daily given partly at home, compared with unfractionated heparin given in the hospital in the treatment of proximal deep‐vein thrombosis, a Brazilian multicenter study. Blood2001;98(11):Abstract 4026. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , DietrichF . An open‐label, comparative study of the efficacy and safety of an outpatient single daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Blood2002;11:503a‐Abstract 1960. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , Dietrich‐NetoF , CLETRAT Investigators. Efficacy and safety of once‐daily enoxaparin given in the outpatient setting compared with in‐hospital unfractionated heparin for treatment of proximal lower limb deep‐vein thrombosis. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1401. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , KaraoglanDM , MichaelisW , et al. An open‐label, comparative study of the efficacy and safety of once‐daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Thrombosis Research2004;114(3):149‐53. ">Ramacciotti 2004</a> trials given that participants randomised to LMWH were treated only at home, as determined by a clinician, but were not specifically assigned to home treatment. This sensitivity analysis did not change the findings. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD003076-sec-0072" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD003076-sec-0072"></div> <section id="CD003076-sec-0073"> <h3 class="title" id="CD003076-sec-0073">Summary of main results</h3> <p>This review presents low‐quality evidence suggesting that patients treated at home with low molecular weight heparin (LMWH) are less likely to have recurrence of venous thromboembolism (VTE) than those treated in an in‐patient (hospital) setting. Data show no clear differences in major or minor bleeding events nor in mortality (all low‐quality evidence), indicating that home treatment is no worse for these outcomes when compared with in‐patient treatment. </p> </section> <section id="CD003076-sec-0074"> <h3 class="title" id="CD003076-sec-0074">Overall completeness and applicability of evidence</h3> <p>Although the results of this review are promising, review authors have several concerns about the applicability of the evidence. Our primary concern is that a large number of participants in the home treatment group were not treated solely at home. Also, there was heterogeneity in the findings of the larger trials, making it difficult to interpret and apply the results. Finally, a large number of eligible participants were excluded from trials before randomisation, raising concerns about applicability. </p> <p>Many of the participants randomised to home treatment with LMWH were not actually treated fully at home but were hospitalised for some or all of the treatment period (see <a href="#CD003076-tbl-0003">Table 2</a> for details). Only 40% (in <a href="./references#CD003076-bbs2-0001" title="BäckmanK , CarlssonP , KentsonM , HansenS , EngquistL , HallertC . Deep venous thrombosis: a new task for primary health care. Scandinavian Journal of Primary Health Care2004;22(1):44‐9. ">Bäckman 2004</a>), 23% (in <a href="./references#CD003076-bbs2-0003" title="ChongBH . A randomized, prospective, multicentre study comparing the efficacy, safety and cost of once‐daily enoxaparin given at home with unfractionated heparin given in hospital in the treatment of deep‐vein thrombosis. Blood2002;100(11):Abstract 2772. ChongBH , BrightonTA , BakerRI , ThurlowP , LeeCH , ASTH DS Group. Once‐daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep‐vein thrombosis. Journal of Thrombosis and Thrombolysis2005;19(3):173‐81. ">Chong 2005</a>), 36% (in <a href="./references#CD003076-bbs2-0005" title="KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of patients with venous thrombosis with intravenous unfractionated heparin in hospital compared with subcutaneous low‐molecular‐weight heparin out of hospital. Annals of Hematology1996;72:A3. KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of venous thrombosis with intravenous unfractionated heparin in hospital as compared with subcutaneous low molecular weight heparin at home. New England Journal of Medicine1996;334(11):682‐7. van denBeltAGM , BossuytPMM , PrinsMH , GallusAS , BullerHR . Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis ‐ an economic evaluation. Thrombosis and Haemostasis1998;79:259‐62. ">Koopman 1996</a>), 48.5% (in <a href="./references#CD003076-bbs2-0006" title="LevineM , GentM , HirschJ , LeclercJ , AndersonD , WeitzJ , et al. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis. New England Journal of Medicine1996;334:677‐82. O'BrienB , LevineM , WillanA , GoereeR , HaleyS , BlackhouseG , et al. Economic evaluation of outpatient treatment with low‐molecular‐weight‐heparin for proximal vein thrombosis. Archives of Internal Medicine1999;159:2298‐304. ">Levine 1996</a>), and 36% (in <a href="./references#CD003076-bbs2-0007" title="RamacciottiE , AraujoGR , LastoriaS , DietrichF , MaffeiFH , MussiNS . The efficacy and safety of enoxaparin once‐daily given partly at home, compared with unfractionated heparin given in the hospital in the treatment of proximal deep‐vein thrombosis, a Brazilian multicenter study. Blood2001;98(11):Abstract 4026. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , DietrichF . An open‐label, comparative study of the efficacy and safety of an outpatient single daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Blood2002;11:503a‐Abstract 1960. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , Dietrich‐NetoF , CLETRAT Investigators. Efficacy and safety of once‐daily enoxaparin given in the outpatient setting compared with in‐hospital unfractionated heparin for treatment of proximal lower limb deep‐vein thrombosis. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1401. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , KaraoglanDM , MichaelisW , et al. An open‐label, comparative study of the efficacy and safety of once‐daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Thrombosis Research2004;114(3):149‐53. ">Ramacciotti 2004</a>) of those randomised to home treatment were treated wholly at home, making trial results difficult to interpret. In three trials, participants randomised to LMWH treatment, as opposed to unfractionated heparin (UFH), could be treated at home or in an in‐patient setting at the discretion of clinicians or investigators (<a href="./references#CD003076-bbs2-0005" title="KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of patients with venous thrombosis with intravenous unfractionated heparin in hospital compared with subcutaneous low‐molecular‐weight heparin out of hospital. Annals of Hematology1996;72:A3. KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of venous thrombosis with intravenous unfractionated heparin in hospital as compared with subcutaneous low molecular weight heparin at home. New England Journal of Medicine1996;334(11):682‐7. van denBeltAGM , BossuytPMM , PrinsMH , GallusAS , BullerHR . Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis ‐ an economic evaluation. Thrombosis and Haemostasis1998;79:259‐62. ">Koopman 1996</a>; <a href="./references#CD003076-bbs2-0006" title="LevineM , GentM , HirschJ , LeclercJ , AndersonD , WeitzJ , et al. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis. New England Journal of Medicine1996;334:677‐82. O'BrienB , LevineM , WillanA , GoereeR , HaleyS , BlackhouseG , et al. Economic evaluation of outpatient treatment with low‐molecular‐weight‐heparin for proximal vein thrombosis. Archives of Internal Medicine1999;159:2298‐304. ">Levine 1996</a>; <a href="./references#CD003076-bbs2-0007" title="RamacciottiE , AraujoGR , LastoriaS , DietrichF , MaffeiFH , MussiNS . The efficacy and safety of enoxaparin once‐daily given partly at home, compared with unfractionated heparin given in the hospital in the treatment of proximal deep‐vein thrombosis, a Brazilian multicenter study. Blood2001;98(11):Abstract 4026. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , DietrichF . An open‐label, comparative study of the efficacy and safety of an outpatient single daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Blood2002;11:503a‐Abstract 1960. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , Dietrich‐NetoF , CLETRAT Investigators. Efficacy and safety of once‐daily enoxaparin given in the outpatient setting compared with in‐hospital unfractionated heparin for treatment of proximal lower limb deep‐vein thrombosis. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1401. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , KaraoglanDM , MichaelisW , et al. An open‐label, comparative study of the efficacy and safety of once‐daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Thrombosis Research2004;114(3):149‐53. ">Ramacciotti 2004</a>). This creates the concern that data collected and reported in meta‐analyses may not directly speak to the question at hand. To address these issues, we conducted extensive sensitivity analyses and found no differences in our findings when we excluded the findings of these studies. This issue is a problem not just with these few trials; rather, it is an overall, possibly insurmountable problem, as deep vein thrombosis (DVT) and its complications by their nature may require in‐patient treatment, even if a person is deemed acceptable for home treatment. However, these trials have shown that patients treated at home with LMWH are less likely to have recurrence of VTE than their counterparts treated in hospital with UFH or LMWH. Also, researchers found that participants preferred to have treatment at home. Concerns presented here most likely contribute to dilution of review conclusions. </p> <div class="table" id="CD003076-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Percentage of participants treated at home</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0001" title="BäckmanK , CarlssonP , KentsonM , HansenS , EngquistL , HallertC . Deep venous thrombosis: a new task for primary health care. Scandinavian Journal of Primary Health Care2004;22(1):44‐9. "><b>Bäckman 2004</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0002" title="BoccalonH , EliasA , ChaleJJ , CadeneA , DumoulinA . Treatment of deep vein thrombosis at home: from theory to medical practice [French]. Bulletin de l'Academie Nationale de Medecine1998;182(1):101‐15. BoccalonH , EliasA , ChaleJJ , CadeneA , GabrielS . Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low‐molecular‐weight heparin: the Vascular Midi‐Pyrenees study. Archives of Internal Medicine2000;160(12):1769‐73. "><b>Boccalon 2000</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0003" title="ChongBH . A randomized, prospective, multicentre study comparing the efficacy, safety and cost of once‐daily enoxaparin given at home with unfractionated heparin given in hospital in the treatment of deep‐vein thrombosis. Blood2002;100(11):Abstract 2772. ChongBH , BrightonTA , BakerRI , ThurlowP , LeeCH , ASTH DS Group. Once‐daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep‐vein thrombosis. Journal of Thrombosis and Thrombolysis2005;19(3):173‐81. "><b>Chong 2005</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0004" title="DaskalopoulosME , DaskalopoulouSS , TzortzisE , SfiridisP , NikolaouA , DimitroulisD , et al. Long‐term treatment of deep venous thrombosis with a low molecular weight heparin (tinzaparin): a prospective randomized trial. European Journal of Vascular and Endovascular Surgery2005;29(6):638‐50. "><b>Daskalopoulos 2005</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0005" title="KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of patients with venous thrombosis with intravenous unfractionated heparin in hospital compared with subcutaneous low‐molecular‐weight heparin out of hospital. Annals of Hematology1996;72:A3. KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of venous thrombosis with intravenous unfractionated heparin in hospital as compared with subcutaneous low molecular weight heparin at home. New England Journal of Medicine1996;334(11):682‐7. van denBeltAGM , BossuytPMM , PrinsMH , GallusAS , BullerHR . Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis ‐ an economic evaluation. Thrombosis and Haemostasis1998;79:259‐62. "><b>Koopman 1996</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0006" title="LevineM , GentM , HirschJ , LeclercJ , AndersonD , WeitzJ , et al. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis. New England Journal of Medicine1996;334:677‐82. O'BrienB , LevineM , WillanA , GoereeR , HaleyS , BlackhouseG , et al. Economic evaluation of outpatient treatment with low‐molecular‐weight‐heparin for proximal vein thrombosis. Archives of Internal Medicine1999;159:2298‐304. "><b>Levine 1996</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0007" title="RamacciottiE , AraujoGR , LastoriaS , DietrichF , MaffeiFH , MussiNS . The efficacy and safety of enoxaparin once‐daily given partly at home, compared with unfractionated heparin given in the hospital in the treatment of proximal deep‐vein thrombosis, a Brazilian multicenter study. Blood2001;98(11):Abstract 4026. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , DietrichF . An open‐label, comparative study of the efficacy and safety of an outpatient single daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Blood2002;11:503a‐Abstract 1960. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , Dietrich‐NetoF , CLETRAT Investigators. Efficacy and safety of once‐daily enoxaparin given in the outpatient setting compared with in‐hospital unfractionated heparin for treatment of proximal lower limb deep‐vein thrombosis. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1401. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , KaraoglanDM , MichaelisW , et al. An open‐label, comparative study of the efficacy and safety of once‐daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Thrombosis Research2004;114(3):149‐53. "><b>Ramacciotti 2004</b> </a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomised (N)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>201</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>298</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>400</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>500</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>201</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Excluded after randomisation (%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomised to home/LMWH treatment and were actually treated at home (not hospitalised) (%) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup><a href="./references#CD003076-bbs2-0001" title="BäckmanK , CarlssonP , KentsonM , HansenS , EngquistL , HallertC . Deep venous thrombosis: a new task for primary health care. Scandinavian Journal of Primary Health Care2004;22(1):44‐9. ">Bäckman 2004</a> reported that 40% of those randomised to home treatment remained at home, and 40% were hospitalised; it is unclear what happened with the remaining 20%; 36 randomised participants changed treatment, 26 of whom changed from hospital to home, and 10 from home to hospital. </p> <p><sup>b</sup><a href="./references#CD003076-bbs2-0003" title="ChongBH . A randomized, prospective, multicentre study comparing the efficacy, safety and cost of once‐daily enoxaparin given at home with unfractionated heparin given in hospital in the treatment of deep‐vein thrombosis. Blood2002;100(11):Abstract 2772. ChongBH , BrightonTA , BakerRI , ThurlowP , LeeCH , ASTH DS Group. Once‐daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep‐vein thrombosis. Journal of Thrombosis and Thrombolysis2005;19(3):173‐81. ">Chong 2005</a> reported that 23% of those randomised to home treatment were exclusively treated at home, 12% were hospitalised and discharged within a day, and 35% were hospitalised for one night, 23% for two nights, and 8% for three or more nights. </p> <p><sup>c</sup><a href="./references#CD003076-bbs2-0004" title="DaskalopoulosME , DaskalopoulouSS , TzortzisE , SfiridisP , NikolaouA , DimitroulisD , et al. Long‐term treatment of deep venous thrombosis with a low molecular weight heparin (tinzaparin): a prospective randomized trial. European Journal of Vascular and Endovascular Surgery2005;29(6):638‐50. ">Daskalopoulos 2005</a> initially reported: "Patients allocated to receive treatment with LMWH underwent no hospitalizations at all", but later in the text trial authors state: "The number of major events requiring hospitalization was significantly lower in the LMWH group", making it unclear whether those randomised to LMWH were exclusively treated at home. </p> <p>LMWH: low molecular weight heparin.</p> </div> </div> <p>The three major randomised controlled trials (RCTs) compared UFH in hospital versus LMWH at home (<a href="./references#CD003076-bbs2-0003" title="ChongBH . A randomized, prospective, multicentre study comparing the efficacy, safety and cost of once‐daily enoxaparin given at home with unfractionated heparin given in hospital in the treatment of deep‐vein thrombosis. Blood2002;100(11):Abstract 2772. ChongBH , BrightonTA , BakerRI , ThurlowP , LeeCH , ASTH DS Group. Once‐daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep‐vein thrombosis. Journal of Thrombosis and Thrombolysis2005;19(3):173‐81. ">Chong 2005</a>; <a href="./references#CD003076-bbs2-0005" title="KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of patients with venous thrombosis with intravenous unfractionated heparin in hospital compared with subcutaneous low‐molecular‐weight heparin out of hospital. Annals of Hematology1996;72:A3. KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of venous thrombosis with intravenous unfractionated heparin in hospital as compared with subcutaneous low molecular weight heparin at home. New England Journal of Medicine1996;334(11):682‐7. van denBeltAGM , BossuytPMM , PrinsMH , GallusAS , BullerHR . Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis ‐ an economic evaluation. Thrombosis and Haemostasis1998;79:259‐62. ">Koopman 1996</a>; <a href="./references#CD003076-bbs2-0006" title="LevineM , GentM , HirschJ , LeclercJ , AndersonD , WeitzJ , et al. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis. New England Journal of Medicine1996;334:677‐82. O'BrienB , LevineM , WillanA , GoereeR , HaleyS , BlackhouseG , et al. Economic evaluation of outpatient treatment with low‐molecular‐weight‐heparin for proximal vein thrombosis. Archives of Internal Medicine1999;159:2298‐304. ">Levine 1996</a>). A more methodologically sound trial would have compared LMWH in both groups, and this would have been justified by the many trials and three meta‐analyses showing that LMWH is at least as effective as UFH (<a href="./references#CD003076-bbs2-0039" title="ErkensPMG , PrinsMH . Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database of Systematic Reviews2010, Issue 9. [DOI: 10.1002/14651858.CD001100.pub3] ">Erkens 2010</a>; <a href="./references#CD003076-bbs2-0046" title="LeizoroviczA , SimmoneauG , DecoususH , BoisselJP . Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep vein thrombosis: a meta‐analysis. BMJ1994;309:299‐304. ">Leizorovicz 1994</a>; <a href="./references#CD003076-bbs2-0047" title="LensingAW , PrinsMH , DavidsonBL , HirshJ . Treatment of deep venous thrombosis with low‐molecular‐weight heparins. A meta‐analysis. Archives of Internal Medicine1995;155(6):601‐7. ">Lensing 1995</a>). </p> <p>Another factor limiting review conclusions was the very high prerandomisation exclusion rate reported by several trials (<a href="./references#CD003076-bbs2-0002" title="BoccalonH , EliasA , ChaleJJ , CadeneA , DumoulinA . Treatment of deep vein thrombosis at home: from theory to medical practice [French]. Bulletin de l'Academie Nationale de Medecine1998;182(1):101‐15. BoccalonH , EliasA , ChaleJJ , CadeneA , GabrielS . Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low‐molecular‐weight heparin: the Vascular Midi‐Pyrenees study. Archives of Internal Medicine2000;160(12):1769‐73. ">Boccalon 2000</a>; <a href="./references#CD003076-bbs2-0005" title="KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of patients with venous thrombosis with intravenous unfractionated heparin in hospital compared with subcutaneous low‐molecular‐weight heparin out of hospital. Annals of Hematology1996;72:A3. KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of venous thrombosis with intravenous unfractionated heparin in hospital as compared with subcutaneous low molecular weight heparin at home. New England Journal of Medicine1996;334(11):682‐7. van denBeltAGM , BossuytPMM , PrinsMH , GallusAS , BullerHR . Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis ‐ an economic evaluation. Thrombosis and Haemostasis1998;79:259‐62. ">Koopman 1996</a>; <a href="./references#CD003076-bbs2-0006" title="LevineM , GentM , HirschJ , LeclercJ , AndersonD , WeitzJ , et al. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis. New England Journal of Medicine1996;334:677‐82. O'BrienB , LevineM , WillanA , GoereeR , HaleyS , BlackhouseG , et al. Economic evaluation of outpatient treatment with low‐molecular‐weight‐heparin for proximal vein thrombosis. Archives of Internal Medicine1999;159:2298‐304. ">Levine 1996</a>). <a href="./references#CD003076-bbs2-0005" title="KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of patients with venous thrombosis with intravenous unfractionated heparin in hospital compared with subcutaneous low‐molecular‐weight heparin out of hospital. Annals of Hematology1996;72:A3. KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of venous thrombosis with intravenous unfractionated heparin in hospital as compared with subcutaneous low molecular weight heparin at home. New England Journal of Medicine1996;334(11):682‐7. van denBeltAGM , BossuytPMM , PrinsMH , GallusAS , BullerHR . Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis ‐ an economic evaluation. Thrombosis and Haemostasis1998;79:259‐62. ">Koopman 1996</a> reported exclusion of 31% of eligible participants, and <a href="./references#CD003076-bbs2-0006" title="LevineM , GentM , HirschJ , LeclercJ , AndersonD , WeitzJ , et al. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis. New England Journal of Medicine1996;334:677‐82. O'BrienB , LevineM , WillanA , GoereeR , HaleyS , BlackhouseG , et al. Economic evaluation of outpatient treatment with low‐molecular‐weight‐heparin for proximal vein thrombosis. Archives of Internal Medicine1999;159:2298‐304. ">Levine 1996</a> reported exclusion of 67%. Similarly, <a href="./references#CD003076-bbs2-0002" title="BoccalonH , EliasA , ChaleJJ , CadeneA , DumoulinA . Treatment of deep vein thrombosis at home: from theory to medical practice [French]. Bulletin de l'Academie Nationale de Medecine1998;182(1):101‐15. BoccalonH , EliasA , ChaleJJ , CadeneA , GabrielS . Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low‐molecular‐weight heparin: the Vascular Midi‐Pyrenees study. Archives of Internal Medicine2000;160(12):1769‐73. ">Boccalon 2000</a> (78%) and <a href="./references#CD003076-bbs2-0001" title="BäckmanK , CarlssonP , KentsonM , HansenS , EngquistL , HallertC . Deep venous thrombosis: a new task for primary health care. Scandinavian Journal of Primary Health Care2004;22(1):44‐9. ">Bäckman 2004</a> (42%) reported high exclusion rates. Exclusion criteria were very diffuse and could have been less strict. <a href="./references#CD003076-bbs2-0004" title="DaskalopoulosME , DaskalopoulouSS , TzortzisE , SfiridisP , NikolaouA , DimitroulisD , et al. Long‐term treatment of deep venous thrombosis with a low molecular weight heparin (tinzaparin): a prospective randomized trial. European Journal of Vascular and Endovascular Surgery2005;29(6):638‐50. ">Daskalopoulos 2005</a> presented a contrasting low exclusion rate (7%). <a href="./references#CD003076-bbs2-0007" title="RamacciottiE , AraujoGR , LastoriaS , DietrichF , MaffeiFH , MussiNS . The efficacy and safety of enoxaparin once‐daily given partly at home, compared with unfractionated heparin given in the hospital in the treatment of proximal deep‐vein thrombosis, a Brazilian multicenter study. Blood2001;98(11):Abstract 4026. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , DietrichF . An open‐label, comparative study of the efficacy and safety of an outpatient single daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Blood2002;11:503a‐Abstract 1960. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , Dietrich‐NetoF , CLETRAT Investigators. Efficacy and safety of once‐daily enoxaparin given in the outpatient setting compared with in‐hospital unfractionated heparin for treatment of proximal lower limb deep‐vein thrombosis. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1401. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , KaraoglanDM , MichaelisW , et al. An open‐label, comparative study of the efficacy and safety of once‐daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Thrombosis Research2004;114(3):149‐53. ">Ramacciotti 2004</a> and <a href="./references#CD003076-bbs2-0003" title="ChongBH . A randomized, prospective, multicentre study comparing the efficacy, safety and cost of once‐daily enoxaparin given at home with unfractionated heparin given in hospital in the treatment of deep‐vein thrombosis. Blood2002;100(11):Abstract 2772. ChongBH , BrightonTA , BakerRI , ThurlowP , LeeCH , ASTH DS Group. Once‐daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep‐vein thrombosis. Journal of Thrombosis and Thrombolysis2005;19(3):173‐81. ">Chong 2005</a> did not report on prerandomisation exclusions, except for three participants in the <a href="./references#CD003076-bbs2-0003" title="ChongBH . A randomized, prospective, multicentre study comparing the efficacy, safety and cost of once‐daily enoxaparin given at home with unfractionated heparin given in hospital in the treatment of deep‐vein thrombosis. Blood2002;100(11):Abstract 2772. ChongBH , BrightonTA , BakerRI , ThurlowP , LeeCH , ASTH DS Group. Once‐daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep‐vein thrombosis. Journal of Thrombosis and Thrombolysis2005;19(3):173‐81. ">Chong 2005</a> trial, who were enrolled but were not randomised because they did not receive study treatment or did not provide treatment‐related data. </p> <p>Although we have included 'economic analysis' as an outcome, a comprehensive economic analysis is beyond the scope/expertise of this review, so we have reported only limited data available from the included studies. </p> <p>Other issues that may affect applicability of our review include the limited number of participants from developing countries, and the fact that no high‐quality RCTs have been published since 2005. </p> <p>Trends in the treatment of individuals with VTE have been changing recently, with practitioners moving away from UFH and using more LMWHs along with the newer class of direct oral anticoagulants (DOACs). Treatment with LMWHs and DOACs has been shown to be efficacious, with no increase in clinically relevant complications (<a href="./references#CD003076-bbs2-0051" title="RobertsonL , KestevenP , McCaslinJE . Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of deep vein thrombosis. Cochrane Database of Systematic Reviews2015, Issue 6. [DOI: 10.1002/14651858.CD010956.pub2] ">Robertson 2015</a>; <a href="./references#CD003076-bbs2-0052" title="RobertsonL , JonesLE . Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism. Cochrane Database of Systematic Reviews2017;Issue 2:Art. No.: CD001100. ">Robertson 2017</a>). Although UFH treatment is not going to disappear completely, practitioners have been moving away from its usage and embracing LMWH and DOACs owing to monitoring requirements and subsequent costs of treatment with UFH. However, clinicians using DOACs to treat patients with VTE have to reckon with their complexity, involving appropriate dose selection for the relevant indication, avoidance of drug‐drug and drug‐disease interactions, and consideration of dose adjustments in specific clinical situations, such as organ dysfunction (<a href="./references#CD003076-bbs2-0040" title="FinksSW , TrujilloTC , DobeshPP . Management of venous thromboembolism. Annals of Pharmacotherapy2016;50(6):486‐501. ">Finks 2016</a>). This review did not evaluate any studies that included the use of DOACs, such as rivaroxaban or dabigatran, as no such studies met our inclusion criteria. We therefore have presented limited evidence in this review for detailed discussion of their use. </p> </section> <section id="CD003076-sec-0075"> <h3 class="title" id="CD003076-sec-0075">Quality of the evidence</h3> <p>Strengths of the evidence include the consistency and homogeneity of results from individual studies, as well as sufficient numbers of participants and events included for each outcome. However, we downgraded evidence generated in this review to low quality owing to concerns about risk of bias of individually included studies, as well as indirectness of the data due to issues surrounding hospitalisation of participants randomised to home treatment, as discussed in the previous section. A major concern associated with risk of bias was selection bias: All seven included studies were at unclear or high risk for concerns with random sequence generation or allocation concealment. Although minimising performance bias would be very difficult owing to the open nature of the treatment, making blinding of participants and personnel nearly impossible, these issues could be addressed in other ways, such as keeping treatment drugs consistent between interventions or demonstrating more stringent control of detection bias. Risk of bias concerns led us to downgrade the quality of evidence by one level. These concerns reduce the robustness of findings. See <a href="./full#CD003076-tbl-0001">summary of findings Table for the main comparison</a> for further information. </p> <p>We conducted sensitivity analysis by evaluating the strength of evidence in light of risk of bias issues, as well as concerns with indirectness, and we found that findings did not change when we removed studies with high risk of bias, or studies that may not have directly contributed to the objectives of the review. </p> <p>We did not investigate publication bias for the review because we included fewer than 10 studies in the individual meta‐analyses, precluding robust results in the funnel plots used to investigate publication bias. </p> </section> <section id="CD003076-sec-0076"> <h3 class="title" id="CD003076-sec-0076">Potential biases in the review process</h3> <p>During the review process, we adhered to all possible measures to reduce potential biases, including conducting a comprehensive search, performing double data extraction, and grading the evidence. We made attempts to identify relevant studies and discussed disagreements thoroughly. </p> </section> <section id="CD003076-sec-0077"> <h3 class="title" id="CD003076-sec-0077">Agreements and disagreements with other studies or reviews</h3> <p>The results of uncontrolled trials encompass a considerable body of evidence (<a href="#CD003076-tbl-0004">Table 3</a>), particularly in relation to practical questions (see <a href="#CD003076-sec-0080">Implications for research</a>). An observational study that included 334 participants concluded that community‐based treatment of individuals with thromboembolism was safe and effective (<a href="./references#CD003076-bbs2-0044" title="HyersTM , SpyropoulosAC , for the INNOVATE Investigators. Community‐based treatment of venous thromboembolism with a low‐molecular‐weight heparin and warfarin. Journal of Thombosis and Thombolysis2007;24(3):225‐32. ">Hyers 2007</a>). Home treatment has also been investigated in specific pathological communities, including individuals with cancer, and was found to be a suitable alternative to in‐patient care (<a href="./references#CD003076-bbs2-0034" title="AgenoW , GrimwoodR , LimbiatiS , DentaliF , SteidlL , WellsPS . Home‐treatment of deep vein thrombosis in patients with cancer. Haematologica2005;90(2):220‐4. ">Ageno 2005</a>). </p> <div class="table" id="CD003076-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Uncontrolled trials ‐ participant demographics</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial author</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Referrals</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Positive scans</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>% home treated</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0016" title="GrauE , RealE , PastorE , VicianoV , AguiloJ . Home treatment of deep vein thrombosis: a two‐years experience of a single institution. Haematologica1998;83(5):438‐41. ">Grau 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0018" title="GreenES , RhodesS , BondS , ThomsonS , TroughtonAH . Outpatient treatment of deep vein thrombosis using low molecular weight heparin. British Journal of Haematology1998;101(Suppl 1):Abstract 234. ">Green 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>373</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>37.5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0022" title="LindmarkerP , HolstromM . Use of low molecular weight heparin (dalteparin), once daily, for the treatment of deep vein thrombosis. A feasibility and health economic study in an outpatient setting. Swedish Venous Thrombosis Dalteparin Trial Group. Journal of Internal Medicine1996;240(6):395‐401. ">Lindmarker 1996</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>434<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0023" title="MilesJ , O'ShaugnesseyD , WimperisJ . Outpatient management of DVT in the United Kingdom. Presentation to American Thoracic Society. 1998. ">Miles 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>966</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0025" title="O'ShaughnessyDF , ToveyC , MillerALC , O'NeillV , RanaPS , AkbarS , et al. Outpatient management of deep vein thrombosis. Journal of Accident and Emergency Medicine1998;15(5):292‐3. ">O'Shaugnessy 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1093</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99.9</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0029" title="TingSBN , ZiegenbeinRW , GanTE , CatalanoJV , MonagleP , SilversJ , et al. Dalteparin for deep vein thrombosis: a hospital‐in‐the‐home program. Medical Journal of Australia1998;168(6):272‐6. ">Ting 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0033" title="WimperisJZ , PoutG , DilksG , WilsonP , ClarkeJ , JenkinsP , et al. Significant bed savings resulting from outpatient management of deep vein thrombosis with low molecular weight heparin. British Journal of Haematology1998;101(Suppl 1):Abstract 231. ">Wimperis 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>447</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>134</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1451</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>3 days' hospital treatment before discharge.<br/> <sup>b</sup>Excluding distal thrombosis. </p> </div> </div> <p>In the UK, some local health authorities (Trusts) have published the results of uncontrolled studies. Swindon Trust reported that 373 patients were referred to the programme, of whom 32% had proven DVT and 37.5% were treated wholly or partially at home (<a href="./references#CD003076-bbs2-0018" title="GreenES , RhodesS , BondS , ThomsonS , TroughtonAH . Outpatient treatment of deep vein thrombosis using low molecular weight heparin. British Journal of Haematology1998;101(Suppl 1):Abstract 234. ">Green 1998</a>). Chertsey Trust reported on 1093 referrals, of which 160 were proven to have a diagnosis of DVT. All but one (i.e. 159 patients) were home‐treated (<a href="./references#CD003076-bbs2-0025" title="O'ShaughnessyDF , ToveyC , MillerALC , O'NeillV , RanaPS , AkbarS , et al. Outpatient management of deep vein thrombosis. Journal of Accident and Emergency Medicine1998;15(5):292‐3. ">O'Shaugnessy 1998</a>). Researchers have reported no complications apart from two minor bleeds and estimated savings to Chertsey Trust as £320,000 over 22 months. In a combined presentation to the American Thoracic Society, three trusts reported that they managed the care of 966 patients with DVT, of whom only 10% were admitted to hospital (<a href="./references#CD003076-bbs2-0023" title="MilesJ , O'ShaugnesseyD , WimperisJ . Outpatient management of DVT in the United Kingdom. Presentation to American Thoracic Society. 1998. ">Miles 1998</a>). In Norwich, 447 patients were referred over a six‐month period, scans were positive in 30%, and 20% of these were considered unsuitable for home treatment (<a href="./references#CD003076-bbs2-0033" title="WimperisJZ , PoutG , DilksG , WilsonP , ClarkeJ , JenkinsP , et al. Significant bed savings resulting from outpatient management of deep vein thrombosis with low molecular weight heparin. British Journal of Haematology1998;101(Suppl 1):Abstract 231. ">Wimperis 1998</a>). Thus, 105 were treated and five had to be readmitted ‐ two with suspected pulmonary embolism (PE) (negative scans), one with PE, one with stroke, and one with an unrelated illness (<a href="./references#CD003076-bbs2-0033" title="WimperisJZ , PoutG , DilksG , WilsonP , ClarkeJ , JenkinsP , et al. Significant bed savings resulting from outpatient management of deep vein thrombosis with low molecular weight heparin. British Journal of Haematology1998;101(Suppl 1):Abstract 231. ">Wimperis 1998</a>). </p> <p>A study from Melbourne presented 100 participants with proven DVT (<a href="./references#CD003076-bbs2-0029" title="TingSBN , ZiegenbeinRW , GanTE , CatalanoJV , MonagleP , SilversJ , et al. Dalteparin for deep vein thrombosis: a hospital‐in‐the‐home program. Medical Journal of Australia1998;168(6):272‐6. ">Ting 1998</a>). Fifty‐three participants had proximal thrombosis and were admitted for one day for investigation, including lung scan: 16 scans were positive, although participants were asymptomatic and the result did not affect their management at home. The 47 participants with distal thrombosis were treated entirely at home. The clot was initially extended in 13.2% of distal and 2.7% of proximal thromboses, but at follow‐up scans at six months, 60.7% of distal and 18.5% of proximal thromboses had completely resolved. The only complications were six minor bleeds. The numbers of participants referred but cleared of DVT, and the numbers rejected by the protocol, were not mentioned. In a Swedish study, 434 participants with DVT were treated in hospital for three days before discharge home on treatment (<a href="./references#CD003076-bbs2-0022" title="LindmarkerP , HolstromM . Use of low molecular weight heparin (dalteparin), once daily, for the treatment of deep vein thrombosis. A feasibility and health economic study in an outpatient setting. Swedish Venous Thrombosis Dalteparin Trial Group. Journal of Internal Medicine1996;240(6):395‐401. ">Lindmarker 1996</a>). Three participants had proven PE: One major bleed and 16 minor ones occurred. Data show no deaths in the acute stage and no extension of thromboses. In <a href="./references#CD003076-bbs2-0016" title="GrauE , RealE , PastorE , VicianoV , AguiloJ . Home treatment of deep vein thrombosis: a two‐years experience of a single institution. Haematologica1998;83(5):438‐41. ">Grau 1998</a>, 39 out of 71 participants with DVT were treated at home. Investigators reported no instance of PE and only one minor bleed. These trials all reported worthwhile cost savings. Only one uncontrolled study reported on patient satisfaction (<a href="./references#CD003076-bbs2-0012" title="ConnerC . Innohep User's meeting, Windsor. Data on file1999. ">Conner 1999</a>). Seventy‐nine per cent of participants were happy to be treated at home, 12% would have preferred hospital treatment, and 9% had no preference. </p> <p>Although not based on evidence from RCTs, cost savings in favour of home treatment have been shown when calculated. Hospital Episode Statistics for the UK for 1993 show 17,000 admissions for PE and 25,000 for DVT, with an average in‐patient stay of 7.2 days (<a href="./references#CD003076-bbs2-0042" title="GriffinJ . Deep venous thrombosis and pulmonary embolism. London: Office of Health Economics, 1996. ">Griffin 1996</a>). At an estimated cost of £200 per in‐patient day (1998 figures), hospitalisation costs alone amounted to £60,480,000. If this could be reduced to, say, two days in 75% of cases, at a cost of £12,600,000, a savings of £47,880,000 on bed costs per annum would be realisable. Although it was not in the remit of this review, it is worth noting that surveillance of participants up to four years after randomisation to home or hospital regimens revealed no differences between groups (<a href="./references#CD003076-bbs2-0017" title="GrauE , TeniasJM , RealE , MedranoJ , FerrerR , PastorE , et al. Home treatment of deep vein thrombosis with low molecular weight heparin: long‐term incidence of recurrent venous thromboembolism. American Journal of Haematology2001;67(1):10‐4. ">Grau 2001</a>). </p> <p>Regarding the results of quality of life outcomes reported in <a href="./references#CD003076-bbs2-0001" title="BäckmanK , CarlssonP , KentsonM , HansenS , EngquistL , HallertC . Deep venous thrombosis: a new task for primary health care. Scandinavian Journal of Primary Health Care2004;22(1):44‐9. ">Bäckman 2004</a>, <a href="./references#CD003076-bbs2-0010" title="BlattlerW , BorerW , LinderC . Outpatient and conventional treatment of acute deep vein thrombosis evaluated in a controlled single‐centre study. Phlébologie1998;51(1):41‐6. BlattlerW , BorerW , LinderC , BerganJ . Outpatient and conventional treatment of acute deep vein thrombosis evaluated in a controlled single‐centre study [Traitements ambulatoire et conventionnel de la thrombose veineuse profonde aigue: Bilan monocentrique]. Phlébologie1998;51(1):33‐9. ">Blattler 1998</a> (excluded from our review as it was not an RCT) observed a similar preference in two‐thirds of participants, who challenged hospital confinement and stated that they would not choose hospitalisation another time. The Blattler trial also reported that its home treatment group was free of symptoms a day earlier and returned to work a week earlier than the hospital treatment group (<a href="./references#CD003076-bbs2-0010" title="BlattlerW , BorerW , LinderC . Outpatient and conventional treatment of acute deep vein thrombosis evaluated in a controlled single‐centre study. Phlébologie1998;51(1):41‐6. BlattlerW , BorerW , LinderC , BerganJ . Outpatient and conventional treatment of acute deep vein thrombosis evaluated in a controlled single‐centre study [Traitements ambulatoire et conventionnel de la thrombose veineuse profonde aigue: Bilan monocentrique]. Phlébologie1998;51(1):33‐9. ">Blattler 1998</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD003076-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/media/CDSR/CD003076/urn:x-wiley:14651858:media:CD003076:CD003076-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/media/CDSR/CD003076/image_t/tCD003076-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD003076-fig-0001" src="/cdsr/doi/10.1002/14651858.CD003076.pub3/media/CDSR/CD003076/image_n/nCD003076-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/full#CD003076-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/media/CDSR/CD003076/image_n/nCD003076-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003076-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/media/CDSR/CD003076/urn:x-wiley:14651858:media:CD003076:CD003076-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/media/CDSR/CD003076/image_t/tCD003076-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD003076-fig-0002" src="/cdsr/doi/10.1002/14651858.CD003076.pub3/media/CDSR/CD003076/image_n/nCD003076-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/full#CD003076-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/media/CDSR/CD003076/image_n/nCD003076-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003076-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/media/CDSR/CD003076/urn:x-wiley:14651858:media:CD003076:CD003076-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/media/CDSR/CD003076/image_t/tCD003076-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD003076-fig-0003" src="/cdsr/doi/10.1002/14651858.CD003076.pub3/media/CDSR/CD003076/image_n/nCD003076-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/full#CD003076-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/media/CDSR/CD003076/image_n/nCD003076-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003076-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/media/CDSR/CD003076/urn:x-wiley:14651858:media:CD003076:CD003076-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/media/CDSR/CD003076/image_t/tCD003076-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Treatment of DVT at home versus treatment in hospital, Outcome 1 Recurrence of VTE." data-id="CD003076-fig-0004" src="/cdsr/doi/10.1002/14651858.CD003076.pub3/media/CDSR/CD003076/image_n/nCD003076-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Treatment of DVT at home versus treatment in hospital, Outcome 1 Recurrence of VTE. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/references#CD003076-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/media/CDSR/CD003076/image_n/nCD003076-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003076-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/media/CDSR/CD003076/urn:x-wiley:14651858:media:CD003076:CD003076-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/media/CDSR/CD003076/image_t/tCD003076-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Treatment of DVT at home versus treatment in hospital, Outcome 2 Major bleeding." data-id="CD003076-fig-0005" src="/cdsr/doi/10.1002/14651858.CD003076.pub3/media/CDSR/CD003076/image_n/nCD003076-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Treatment of DVT at home versus treatment in hospital, Outcome 2 Major bleeding. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/references#CD003076-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/media/CDSR/CD003076/image_n/nCD003076-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003076-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/media/CDSR/CD003076/urn:x-wiley:14651858:media:CD003076:CD003076-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/media/CDSR/CD003076/image_t/tCD003076-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Treatment of DVT at home versus treatment in hospital, Outcome 3 Minor bleeding." data-id="CD003076-fig-0006" src="/cdsr/doi/10.1002/14651858.CD003076.pub3/media/CDSR/CD003076/image_n/nCD003076-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Treatment of DVT at home versus treatment in hospital, Outcome 3 Minor bleeding. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/references#CD003076-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/media/CDSR/CD003076/image_n/nCD003076-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD003076-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/media/CDSR/CD003076/urn:x-wiley:14651858:media:CD003076:CD003076-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/media/CDSR/CD003076/image_t/tCD003076-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Treatment of DVT at home versus treatment in hospital, Outcome 4 Death." data-id="CD003076-fig-0007" src="/cdsr/doi/10.1002/14651858.CD003076.pub3/media/CDSR/CD003076/image_n/nCD003076-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Treatment of DVT at home versus treatment in hospital, Outcome 4 Death.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/references#CD003076-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/media/CDSR/CD003076/image_n/nCD003076-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD003076-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Treatment of DVT at home compared with treatment in hospital</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>How does treatment of DVT at home compare with treatment in hospital?</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with diagnosed DVT<br/> <b>Setting:</b> hospital and home<br/> <b>Intervention:</b> treatment of DVT at home with LMWH<sup>a</sup><br/> <b>Comparison:</b> treatment of DVT in hospital with UFH or LMWH<sup>b</sup> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)<br/> Follow‐up</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk with treatment of DVT in hospital</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="1" valign="top"> <p><b>Risk difference with treatment of DVT at home</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Recurrence of VTE</b><br/> Follow‐up: range 3 months to 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>1708<br/> (6 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>c,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.58<br/> (0.39 to 0.86) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>31 fewer per 1000<br/> (45 fewer to 10 fewer) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Venous gangrene</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="5" rowspan="1" valign="top"> <p>See comment.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This outcome was not reported by any of the included studies.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Major bleeding</b><br/> Follow‐up: range 14 days to 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>1708<br/> (6 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>c,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.67<br/> (0.33 to 1.36) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7 fewer per 1000<br/> (14 fewer to 8 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Minor bleeding</b><br/> Follow‐up: range 14 days to 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>1708<br/> (6 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>c,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.29<br/> (0.94 to 1.78) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>72 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21 more per 1000<br/> (4 fewer to 56 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Death</b><br/> fFollow‐up: range 3 months to 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>1708<br/> (6 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>c,d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.69<br/> (0.44 to 1.09) </p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49 per 1000</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15 fewer per 1000<br/> (28 fewer to 4 more) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Patient satisfaction/Quality of life</b><br/> Follow‐up: range 7 days to 6 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1031<br/> (3 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>c,d,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>See comment.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Two studies reported greater improvement in QoL among participants treated at home than among those receiving in‐patient treatment; the third study reported that a large number of participants chose to switch from in‐patient care to home‐based care, suggesting this may be patients' preferred option. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cost‐effectiveness</b><sup>f</sup><br/> Follow‐up: range 10 days to 6 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>834<br/> (4 RCTs) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>c,d,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>See comment.</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>One study carried out a randomised economic evaluation and reported that total direct costs were higher for participants in the in‐patient strategy group (i.e. Swedish Crown (SEK) 16,400 per participant (Euro (EUR) 1899) compared with SEK 12,100 per participant (EUR 1405)) than for those in the out‐patient (home) strategy group (P &lt; 0.0010). This was supported by 3 other studies that reported on costs. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*We calculated the assumed risk of the hospital treatment group from the average risk in the hospital treatment group (i.e. the number of participants with events divided by the total number of participants in the hospital treatment group included in the meta‐analysis). <b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> CI: confidence interval; DVT: deep vein thrombosis; LMWH: low molecular weight heparin; RR: risk ratio; UFH: unfractionated heparin; VTE: venous thromboembolism. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence.</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Home treatment refers to treatment for DVT with an LMWH that occurs outside of a hospital or in‐patient setting and can include the medication being administered by the participant or by a caregiver.<br/> <sup>b</sup>Hospital treatment refers to treatment for DVT with an LMWH or a UFH in a hospital or in‐patient setting that is administered by care staff.<br/> <sup>c</sup>Downgraded one level owing to risk of bias from unclear randomisation techniques and blinding measures in most included studies.<br/> <sup>d</sup>Downgraded one level owing to indirectness because most of the included studies had few participants actually treated at home with an LMWH, and many were treated in hospital.<br/> <sup>e</sup>Downgraded one level owing to heterogeneity because the included studies used different methods and time points for gathering information on this outcome.<br/> <sup>f</sup>We are reporting on the cost‐effectiveness analysis reported in the included studies. We have not carried out an economic analysis ourselves. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Treatment of DVT at home compared with treatment in hospital</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/full#CD003076-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003076-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of outcomes</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Setting</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of participants entered</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Heparin type</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean hospital stay (days)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Recurrence of VTE (%)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Major bleeding (%)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Minor bleeding (%)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Death (%)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean total direct costs per participant</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0001" title="BäckmanK , CarlssonP , KentsonM , HansenS , EngquistL , HallertC . Deep venous thrombosis: a new task for primary health care. Scandinavian Journal of Primary Health Care2004;22(1):44‐9. ">Bäckman 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hospital</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>LMWH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>SEK 16,400</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Home</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>LMWH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>SEK 12,100</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0002" title="BoccalonH , EliasA , ChaleJJ , CadeneA , DumoulinA . Treatment of deep vein thrombosis at home: from theory to medical practice [French]. Bulletin de l'Academie Nationale de Medecine1998;182(1):101‐15. BoccalonH , EliasA , ChaleJJ , CadeneA , GabrielS . Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low‐molecular‐weight heparin: the Vascular Midi‐Pyrenees study. Archives of Internal Medicine2000;160(12):1769‐73. ">Boccalon 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hospital</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>LMWH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fr 20,932</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Home</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>LMWH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fr 9230</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0003" title="ChongBH . A randomized, prospective, multicentre study comparing the efficacy, safety and cost of once‐daily enoxaparin given at home with unfractionated heparin given in hospital in the treatment of deep‐vein thrombosis. Blood2002;100(11):Abstract 2772. ChongBH , BrightonTA , BakerRI , ThurlowP , LeeCH , ASTH DS Group. Once‐daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep‐vein thrombosis. Journal of Thrombosis and Thrombolysis2005;19(3):173‐81. ">Chong 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hospital</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UFH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Home</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>LMWH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0004" title="DaskalopoulosME , DaskalopoulouSS , TzortzisE , SfiridisP , NikolaouA , DimitroulisD , et al. Long‐term treatment of deep venous thrombosis with a low molecular weight heparin (tinzaparin): a prospective randomized trial. European Journal of Vascular and Endovascular Surgery2005;29(6):638‐50. ">Daskalopoulos 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hospital</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UFH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Home</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>LMWH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0005" title="KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of patients with venous thrombosis with intravenous unfractionated heparin in hospital compared with subcutaneous low‐molecular‐weight heparin out of hospital. Annals of Hematology1996;72:A3. KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of venous thrombosis with intravenous unfractionated heparin in hospital as compared with subcutaneous low molecular weight heparin at home. New England Journal of Medicine1996;334(11):682‐7. van denBeltAGM , BossuytPMM , PrinsMH , GallusAS , BullerHR . Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis ‐ an economic evaluation. Thrombosis and Haemostasis1998;79:259‐62. ">Koopman 1996</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hospital</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UFH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Home</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>202</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>LMWH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0006" title="LevineM , GentM , HirschJ , LeclercJ , AndersonD , WeitzJ , et al. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis. New England Journal of Medicine1996;334:677‐82. O'BrienB , LevineM , WillanA , GoereeR , HaleyS , BlackhouseG , et al. Economic evaluation of outpatient treatment with low‐molecular‐weight‐heparin for proximal vein thrombosis. Archives of Internal Medicine1999;159:2298‐304. ">Levine 1996</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hospital</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>253</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UFH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Home</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>247</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>LMWH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0007" title="RamacciottiE , AraujoGR , LastoriaS , DietrichF , MaffeiFH , MussiNS . The efficacy and safety of enoxaparin once‐daily given partly at home, compared with unfractionated heparin given in the hospital in the treatment of proximal deep‐vein thrombosis, a Brazilian multicenter study. Blood2001;98(11):Abstract 4026. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , DietrichF . An open‐label, comparative study of the efficacy and safety of an outpatient single daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Blood2002;11:503a‐Abstract 1960. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , Dietrich‐NetoF , CLETRAT Investigators. Efficacy and safety of once‐daily enoxaparin given in the outpatient setting compared with in‐hospital unfractionated heparin for treatment of proximal lower limb deep‐vein thrombosis. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1401. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , KaraoglanDM , MichaelisW , et al. An open‐label, comparative study of the efficacy and safety of once‐daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Thrombosis Research2004;114(3):149‐53. ">Ramacciotti 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hospital</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>LMWH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Home</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>UFH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="10"> <div class="table-footnote"> <p>LMWH: low molecular weight heparin.<br/> UFH: unfractionated heparin.<br/> VTE: venous thromboembolism. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of outcomes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/full#CD003076-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003076-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Percentage of participants treated at home</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0001" title="BäckmanK , CarlssonP , KentsonM , HansenS , EngquistL , HallertC . Deep venous thrombosis: a new task for primary health care. Scandinavian Journal of Primary Health Care2004;22(1):44‐9. "><b>Bäckman 2004</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0002" title="BoccalonH , EliasA , ChaleJJ , CadeneA , DumoulinA . Treatment of deep vein thrombosis at home: from theory to medical practice [French]. Bulletin de l'Academie Nationale de Medecine1998;182(1):101‐15. BoccalonH , EliasA , ChaleJJ , CadeneA , GabrielS . Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low‐molecular‐weight heparin: the Vascular Midi‐Pyrenees study. Archives of Internal Medicine2000;160(12):1769‐73. "><b>Boccalon 2000</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0003" title="ChongBH . A randomized, prospective, multicentre study comparing the efficacy, safety and cost of once‐daily enoxaparin given at home with unfractionated heparin given in hospital in the treatment of deep‐vein thrombosis. Blood2002;100(11):Abstract 2772. ChongBH , BrightonTA , BakerRI , ThurlowP , LeeCH , ASTH DS Group. Once‐daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep‐vein thrombosis. Journal of Thrombosis and Thrombolysis2005;19(3):173‐81. "><b>Chong 2005</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0004" title="DaskalopoulosME , DaskalopoulouSS , TzortzisE , SfiridisP , NikolaouA , DimitroulisD , et al. Long‐term treatment of deep venous thrombosis with a low molecular weight heparin (tinzaparin): a prospective randomized trial. European Journal of Vascular and Endovascular Surgery2005;29(6):638‐50. "><b>Daskalopoulos 2005</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0005" title="KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of patients with venous thrombosis with intravenous unfractionated heparin in hospital compared with subcutaneous low‐molecular‐weight heparin out of hospital. Annals of Hematology1996;72:A3. KoopmanMMW , PrandoniP , PiovellaF , OckelfordPA , BrandjesDPM , van derMeerJ , et al. Treatment of venous thrombosis with intravenous unfractionated heparin in hospital as compared with subcutaneous low molecular weight heparin at home. New England Journal of Medicine1996;334(11):682‐7. van denBeltAGM , BossuytPMM , PrinsMH , GallusAS , BullerHR . Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis ‐ an economic evaluation. Thrombosis and Haemostasis1998;79:259‐62. "><b>Koopman 1996</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0006" title="LevineM , GentM , HirschJ , LeclercJ , AndersonD , WeitzJ , et al. A comparison of low molecular weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis. New England Journal of Medicine1996;334:677‐82. O'BrienB , LevineM , WillanA , GoereeR , HaleyS , BlackhouseG , et al. Economic evaluation of outpatient treatment with low‐molecular‐weight‐heparin for proximal vein thrombosis. Archives of Internal Medicine1999;159:2298‐304. "><b>Levine 1996</b> </a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0007" title="RamacciottiE , AraujoGR , LastoriaS , DietrichF , MaffeiFH , MussiNS . The efficacy and safety of enoxaparin once‐daily given partly at home, compared with unfractionated heparin given in the hospital in the treatment of proximal deep‐vein thrombosis, a Brazilian multicenter study. Blood2001;98(11):Abstract 4026. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , DietrichF . An open‐label, comparative study of the efficacy and safety of an outpatient single daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Blood2002;11:503a‐Abstract 1960. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , Dietrich‐NetoF , CLETRAT Investigators. Efficacy and safety of once‐daily enoxaparin given in the outpatient setting compared with in‐hospital unfractionated heparin for treatment of proximal lower limb deep‐vein thrombosis. Journal of Thrombosis and Haemostasis2003;1(Suppl 1):Abstract P1401. RamacciottiE , AraujoGR , LastoriaS , MaffeiFH , KaraoglanDM , MichaelisW , et al. An open‐label, comparative study of the efficacy and safety of once‐daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep‐vein thrombosis. Thrombosis Research2004;114(3):149‐53. "><b>Ramacciotti 2004</b> </a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomised (N)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>131</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>201</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>298</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>400</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>500</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>201</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Excluded after randomisation (%)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Randomised to home/LMWH treatment and were actually treated at home (not hospitalised) (%) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p><sup>a</sup><a href="./references#CD003076-bbs2-0001" title="BäckmanK , CarlssonP , KentsonM , HansenS , EngquistL , HallertC . Deep venous thrombosis: a new task for primary health care. Scandinavian Journal of Primary Health Care2004;22(1):44‐9. ">Bäckman 2004</a> reported that 40% of those randomised to home treatment remained at home, and 40% were hospitalised; it is unclear what happened with the remaining 20%; 36 randomised participants changed treatment, 26 of whom changed from hospital to home, and 10 from home to hospital. </p> <p><sup>b</sup><a href="./references#CD003076-bbs2-0003" title="ChongBH . A randomized, prospective, multicentre study comparing the efficacy, safety and cost of once‐daily enoxaparin given at home with unfractionated heparin given in hospital in the treatment of deep‐vein thrombosis. Blood2002;100(11):Abstract 2772. ChongBH , BrightonTA , BakerRI , ThurlowP , LeeCH , ASTH DS Group. Once‐daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep‐vein thrombosis. Journal of Thrombosis and Thrombolysis2005;19(3):173‐81. ">Chong 2005</a> reported that 23% of those randomised to home treatment were exclusively treated at home, 12% were hospitalised and discharged within a day, and 35% were hospitalised for one night, 23% for two nights, and 8% for three or more nights. </p> <p><sup>c</sup><a href="./references#CD003076-bbs2-0004" title="DaskalopoulosME , DaskalopoulouSS , TzortzisE , SfiridisP , NikolaouA , DimitroulisD , et al. Long‐term treatment of deep venous thrombosis with a low molecular weight heparin (tinzaparin): a prospective randomized trial. European Journal of Vascular and Endovascular Surgery2005;29(6):638‐50. ">Daskalopoulos 2005</a> initially reported: "Patients allocated to receive treatment with LMWH underwent no hospitalizations at all", but later in the text trial authors state: "The number of major events requiring hospitalization was significantly lower in the LMWH group", making it unclear whether those randomised to LMWH were exclusively treated at home. </p> <p>LMWH: low molecular weight heparin.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Percentage of participants treated at home</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/full#CD003076-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD003076-tbl-0004"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Uncontrolled trials ‐ participant demographics</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial author</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Referrals</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Positive scans</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>% home treated</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0016" title="GrauE , RealE , PastorE , VicianoV , AguiloJ . Home treatment of deep vein thrombosis: a two‐years experience of a single institution. Haematologica1998;83(5):438‐41. ">Grau 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0018" title="GreenES , RhodesS , BondS , ThomsonS , TroughtonAH . Outpatient treatment of deep vein thrombosis using low molecular weight heparin. British Journal of Haematology1998;101(Suppl 1):Abstract 234. ">Green 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>373</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>37.5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0022" title="LindmarkerP , HolstromM . Use of low molecular weight heparin (dalteparin), once daily, for the treatment of deep vein thrombosis. A feasibility and health economic study in an outpatient setting. Swedish Venous Thrombosis Dalteparin Trial Group. Journal of Internal Medicine1996;240(6):395‐401. ">Lindmarker 1996</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>434<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0023" title="MilesJ , O'ShaugnesseyD , WimperisJ . Outpatient management of DVT in the United Kingdom. Presentation to American Thoracic Society. 1998. ">Miles 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>966</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0025" title="O'ShaughnessyDF , ToveyC , MillerALC , O'NeillV , RanaPS , AkbarS , et al. Outpatient management of deep vein thrombosis. Journal of Accident and Emergency Medicine1998;15(5):292‐3. ">O'Shaugnessy 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1093</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99.9</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0029" title="TingSBN , ZiegenbeinRW , GanTE , CatalanoJV , MonagleP , SilversJ , et al. Dalteparin for deep vein thrombosis: a hospital‐in‐the‐home program. Medical Journal of Australia1998;168(6):272‐6. ">Ting 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD003076-bbs2-0033" title="WimperisJZ , PoutG , DilksG , WilsonP , ClarkeJ , JenkinsP , et al. Significant bed savings resulting from outpatient management of deep vein thrombosis with low molecular weight heparin. British Journal of Haematology1998;101(Suppl 1):Abstract 231. ">Wimperis 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>447</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>134</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80.0</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1451</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><sup>a</sup>3 days' hospital treatment before discharge.<br/> <sup>b</sup>Excluding distal thrombosis. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Uncontrolled trials ‐ participant demographics</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/full#CD003076-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD003076-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Treatment of DVT at home versus treatment in hospital</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Recurrence of VTE <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1708</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.39, 0.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Major bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1708</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.33, 1.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Minor bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1708</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.94, 1.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1708</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.44, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Treatment of DVT at home versus treatment in hospital</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD003076.pub3/references#CD003076-tbl-0005">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD003076.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD003076-note-0010">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD003076-note-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD003076-note-0003">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD003076-note-0002">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD003076-note-0001">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003076\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003076\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003076\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003076\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003076\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003076\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003076\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003076\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003076\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003076\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003076\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003076\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003076\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003076\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003076\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD003076\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD003076\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD003076\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=z6k50IFd&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003076.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD003076.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD003076.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD003076.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD003076.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740714964689"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD003076.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740714964693"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD003076.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d7b860bef9368',t:'MTc0MDcxNDk2NS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 